| Year |
Citation |
Score |
| 2024 |
Papadimitriou N, Qu C, Harrison TA, Bever AM, Martin RM, Tsilidis KK, Newcomb PA, Thibodeau SN, Newton CC, Um CY, Obón-Santacana M, Moreno V, Brenner H, Mandic M, Chang-Claude J, ... ... Gallinger S, et al. Body size and risk of colorectal cancer molecular defined subtypes and pathways: Mendelian randomization analyses. Ebiomedicine. 101: 105010. PMID 38350331 DOI: 10.1016/j.ebiom.2024.105010 |
0.345 |
|
| 2023 |
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, et al. Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 41: 4714-4720. PMID 37847995 DOI: 10.1200/JCO.22.02770 |
0.335 |
|
| 2023 |
Tsang ES, Gallinger S. Deciphering the Pathways to PARP Sensitivity in Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 37787975 DOI: 10.1158/1078-0432.CCR-23-2260 |
0.333 |
|
| 2023 |
Bacher JW, Udho EB, Strauss EE, Vyazunova I, Gallinger S, Buchanan DD, Pai RK, Templeton AS, Storts DR, Eshleman JR, Halberg RB. A Highly Sensitive Pan-Cancer Test for Microsatellite Instability. The Journal of Molecular Diagnostics : Jmd. PMID 37544360 DOI: 10.1016/j.jmoldx.2023.07.003 |
0.402 |
|
| 2023 |
Georgeson P, Steinfelder RS, Harrison TA, Pope BJ, Zaidi SH, Qu C, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Aglago EK, Berndt SI, Brenner H, Campbell PT, ... ... Gallinger S, et al. Genotoxic colibactin mutational signature in colorectal cancer is associated with clinicopathological features, specific genomic alterations and better survival. Medrxiv : the Preprint Server For Health Sciences. PMID 37090539 DOI: 10.1101/2023.03.10.23287127 |
0.396 |
|
| 2023 |
Aronson M, Gryfe R, Choi YH, Semotiuk K, Holter S, Ward T, Gallinger S, Cohen Z, Briollais L. Evaluating Colonoscopy Screening Intervals in Patients with Lynch Syndrome from a Large Canadian Registry. Journal of the National Cancer Institute. PMID 36964717 DOI: 10.1093/jnci/djad058 |
0.692 |
|
| 2023 |
Lindström S, Wang L, Feng H, Majumdar A, Huo S, Macdonald J, Harrison T, Turman C, Chen H, Mancuso N, Bammler T, Gallinger S, Gruber SB, Gunter MJ, Le Marchand L, et al. Genome-Wide Analyses Characterize Shared Heritability Among Cancers and Identify Novel Cancer Susceptibility Regions. Journal of the National Cancer Institute. PMID 36929942 DOI: 10.1093/jnci/djad043 |
0.357 |
|
| 2023 |
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, Díez-Obrero V, Hsu L, Fernandez-Tajes J, Palles C, Sherwood K, Briggs S, Svinti V, Donnelly K, Farrington S, ... ... Gallinger S, et al. Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nature Genetics. PMID 36782065 DOI: 10.1038/s41588-023-01334-w |
0.328 |
|
| 2023 |
Ugai T, Haruki K, Harrison TA, Cao Y, Qu C, Chan AT, Campbell PT, Akimoto N, Berndt S, Brenner H, Buchanan DD, Chang-Claude J, Fujiyoshi K, Gallinger SJ, Gunter MJ, et al. Molecular Characteristics of Early-Onset Colorectal Cancer According to Detailed Anatomical Locations: Comparison With Later-Onset Cases. The American Journal of Gastroenterology. PMID 36707929 DOI: 10.14309/ajg.0000000000002171 |
0.347 |
|
| 2023 |
Ugai T, Akimoto N, Haruki K, Harrison TA, Cao Y, Qu C, Chan AT, Campbell PT, Berndt SI, Buchanan DD, Cross AJ, Diergaarde B, Gallinger SJ, Gunter MJ, Harlid S, et al. Prognostic role of detailed colorectal location and tumor molecular features: analyses of 13,101 colorectal cancer patients including 2994 early-onset cases. Journal of Gastroenterology. PMID 36648535 DOI: 10.1007/s00535-023-01955-2 |
0.355 |
|
| 2023 |
Su YR, Sakoda LC, Jeon J, Thomas M, Lin Y, Schneider JL, Udaltsova N, Lee JK, Lansdorp-Vogelaar I, Peterse EFP, Zauber AG, Zheng J, Zheng Y, Hauser E, Baron JA, ... ... Gallinger SJ, et al. Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36622766 DOI: 10.1158/1055-9965.EPI-22-0817 |
0.301 |
|
| 2022 |
Fernandez-Rozadilla C, Timofeeva M, Chen Z, Law P, Thomas M, Schmit S, Díez-Obrero V, Hsu L, Fernandez-Tajes J, Palles C, Sherwood K, Briggs S, Svinti V, Donnelly K, Farrington S, ... ... Gallinger S, et al. Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries. Nature Genetics. PMID 36539618 DOI: 10.1038/s41588-022-01222-9 |
0.35 |
|
| 2022 |
Murphy N, Newton CC, Song M, Papadimitriou N, Hoffmeister M, Phipps AI, Harrison TA, Newcomb PA, Aglago EK, Berndt SI, Brenner H, Buchanan DD, Cao Y, Chan AT, Chen X, ... ... Gallinger S, et al. Body Mass Index and Molecular Subtypes of Colorectal Cancer. Journal of the National Cancer Institute. PMID 36445035 DOI: 10.1093/jnci/djac215 |
0.331 |
|
| 2022 |
Zatzman M, Fuligni F, Ripsman R, Suwal T, Comitani F, Edward LM, Denroche R, Jang GH, Notta F, Gallinger S, Selvanathan SP, Toretsky JA, Hellmann MD, Tabori U, Huang A, et al. Widespread hypertranscription in aggressive human cancers. Science Advances. 8: eabn0238. PMID 36417526 DOI: 10.1126/sciadv.abn0238 |
0.346 |
|
| 2022 |
Møller P, Seppälä T, Dowty JG, Haupt S, Dominguez-Valentin M, Sunde L, Bernstein I, Engel C, Aretz S, Nielsen M, Capella G, Evans DG, Burn J, Holinski-Feder E, Bertario L, ... ... Gallinger S, et al. Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium. Hereditary Cancer in Clinical Practice. 20: 36. PMID 36182917 DOI: 10.1186/s13053-022-00241-1 |
0.391 |
|
| 2022 |
Barfield R, Qu C, Steinfelder RS, Zeng C, Harrison TA, Brezina S, Buchanan DD, Campbell PT, Casey G, Gallinger S, Giannakis M, Gruber SB, Gsur A, Hsu L, Huyghe JR, et al. Association between germline variants and somatic mutations in colorectal cancer. Scientific Reports. 12: 10207. PMID 35715570 DOI: 10.1038/s41598-022-14408-2 |
0.375 |
|
| 2022 |
Wang Y, Cuggia A, Chen YI, Parent J, Stanek A, Denroche RE, Zhang A, Grant RC, Domecq C, Golesworthy B, Shwaartz C, Borgida A, Holter S, Wilson JM, Chong G, ... ... Gallinger S, et al. Is Biannual Surveillance for Pancreatic Cancer Sufficient in Individuals With Genetic Syndromes or Familial Pancreatic Cancer? Journal of the National Comprehensive Cancer Network : Jnccn. 20: 663-673.e12. PMID 35714671 DOI: 10.6004/jnccn.2021.7107 |
0.374 |
|
| 2022 |
O'Kane GM, Grünwald BT, Jang GH, Masoomian M, Picardo S, Grant RC, Denroche RE, Zhang A, Wang Y, Miller JK, Lam B, Krzyzanowski PM, Lungu IM, Bartlett JMS, Peralta M, ... ... Gallinger S, et al. Correction: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 28: 2715. PMID 35694787 DOI: 10.1158/1078-0432.CCR-22-1272 |
0.328 |
|
| 2022 |
Georgeson P, Harrison TA, Pope BJ, Zaidi SH, Qu C, Steinfelder RS, Lin Y, Joo JE, Mahmood K, Clendenning M, Walker R, Amitay EL, Berndt SI, Brenner H, Campbell PT, ... ... Gallinger S, et al. Identifying colorectal cancer caused by biallelic MUTYH pathogenic variants using tumor mutational signatures. Nature Communications. 13: 3254. PMID 35668106 DOI: 10.1038/s41467-022-30916-1 |
0.423 |
|
| 2022 |
Tian Y, Kim AE, Bien SA, Lin Y, Qu C, Harrison T, Carreras-Torres R, Díez-Obrero V, Dimou N, Drew DA, Hidaka A, Huyghe JR, Jordahl KM, Morrison J, Murphy N, ... ... Gallinger S, et al. Genome-Wide Interaction Analysis of Genetic Variants with Menopausal Hormone Therapy for Colorectal Cancer Risk. Journal of the National Cancer Institute. PMID 35512400 DOI: 10.1093/jnci/djac094 |
0.308 |
|
| 2022 |
Jordahl KM, Shcherbina A, Kim AE, Su YR, Lin Y, Wang J, Qu C, Albanes D, Arndt V, Baurley JW, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, ... ... Gallinger S, et al. Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. OF1-OF13. PMID 35438744 DOI: 10.1158/1055-9965.EPI-21-1003 |
0.355 |
|
| 2022 |
Harlid S, Van Guelpen B, Qu C, Gylling B, Aglago EK, Amitay EL, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Drew DA, Figueiredo JC, French AJ, ... Gallinger S, et al. Diabetes mellitus in relation to colorectal tumor molecular subtypes - a pooled analysis of more than 9,000 cases. International Journal of Cancer. PMID 35383926 DOI: 10.1002/ijc.34015 |
0.393 |
|
| 2022 |
Barfield R, Huyghe JR, Lemire M, Dong X, Su YR, Brezina S, Buchanan DD, Figueiredo JC, Gallinger S, Giannakis M, Gsur A, Gunter MJ, Hampel H, Harrison TA, Hopper JL, et al. Genetic regulation of DNA methylation yields novel discoveries in GWAS of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35247911 DOI: 10.1158/1055-9965.EPI-21-0724 |
0.311 |
|
| 2022 |
Smith AL, Wong C, Cuggia A, Borgida A, Holter S, Hall A, Connor AA, Bascuñana C, Asselah J, Bouganim N, Poulin V, Jolivet J, Vafiadis P, Le P, Martel G, ... ... Gallinger S, et al. Reflex Testing for Germline , , , and Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries. Jco Precision Oncology. 2: 1-16. PMID 35135108 DOI: 10.1200/PO.17.00098 |
0.306 |
|
| 2022 |
Kim SR, Tone A, Kim R, Cesari M, Clarke B, Hart T, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, Djordjevic B, et al. Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 35012974 DOI: 10.1136/ijgc-2021-003082 |
0.316 |
|
| 2022 |
Labadie JD, Savas S, Harrison TA, Banbury B, Huang Y, Buchanan DD, Campbell PT, Gallinger SJ, Giles GG, Gunter MJ, Hoffmeister M, Hsu L, Jenkins MA, Lin Y, Ogino S, et al. Genome-wide association study identifies tumor anatomical site-specific risk variants for colorectal cancer survival. Scientific Reports. 12: 127. PMID 34996992 DOI: 10.1038/s41598-021-03945-x |
0.317 |
|
| 2021 |
Wills C, He Y, Summers MG, Lin Y, Phipps AI, Watts K, Law PJ, Al-Tassan NA, Maughan TS, Kaplan R, Houlston RS, Peters U, Newcomb PA, Chan AT, Buchanan DD, ... Gallinger S, et al. A genome-wide search for determinants of survival in 1926 patients with advanced colorectal cancer with follow-up in over 22,000 patients. European Journal of Cancer (Oxford, England : 1990). 159: 247-258. PMID 34794066 DOI: 10.1016/j.ejca.2021.09.047 |
0.368 |
|
| 2021 |
Connor AA, Gallinger S. Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data. Nature Reviews. Cancer. 22: 131-142. PMID 34789870 DOI: 10.1038/s41568-021-00418-1 |
0.355 |
|
| 2021 |
Lee DD, Komosa M, Sudhaman S, Leão R, Zhang CH, Apolonio JD, Hermanns T, Wild PJ, Klocker H, Nassiri F, Zadeh G, Diplas BH, Yan H, Gallinger S, Pugh TJ, et al. Dual role of allele-specific DNA hypermethylation within the TERT promoter in cancer. The Journal of Clinical Investigation. 131. PMID 34720085 DOI: 10.1172/JCI146915 |
0.349 |
|
| 2021 |
Blackford AL, Childs EJ, Porter N, Petersen GM, Rabe KG, Gallinger S, Borgida A, Syngal S, Cote ML, Schwartz AG, Goggins MG, Hruban RH, Parmigiani G, Klein AP. A risk prediction tool for individuals with a family history of breast, ovarian, or pancreatic cancer: BRCAPANCPRO. British Journal of Cancer. PMID 34703010 DOI: 10.1038/s41416-021-01580-x |
0.36 |
|
| 2021 |
Hsu FC, Roberts NJ, Childs E, Porter N, Rabe KG, Borgida A, Ukaegbu C, Goggins MG, Hruban RH, Zogopoulos G, Syngal S, Gallinger S, Petersen GM, Klein AP. Risk of Pancreatic Cancer Among Individuals With Pathogenic Variants in the ATM Gene. Jama Oncology. PMID 34529012 DOI: 10.1001/jamaoncol.2021.3701 |
0.394 |
|
| 2021 |
Wang X, Amitay E, Harrison TA, Banbury BL, Berndt SI, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chang-Claude J, Gallinger SJ, Giannakis M, Giles GG, Gunter MJ, et al. Association Between Smoking and Molecular Subtypes of Colorectal Cancer. Jnci Cancer Spectrum. 5: pkab056. PMID 34377935 DOI: 10.1093/jncics/pkab056 |
0.308 |
|
| 2021 |
Dominguez-Valentin M, Plazzer JP, Sampson JR, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Macrae F, Winship IM, Thomas H, Evans DG, Burn J, ... ... Gallinger S, et al. No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in and : A Prospective Lynch Syndrome Database Study. Journal of Clinical Medicine. 10. PMID 34203177 DOI: 10.3390/jcm10132856 |
0.384 |
|
| 2021 |
Archambault AN, Lin Y, Jeon J, Harrison TA, Bishop DT, Brenner H, Casey G, Chan AT, Chang-Claude J, Figueiredo JC, Gallinger S, Gruber SB, Gunter MJ, Hoffmeister M, Jenkins MA, et al. Nongenetic Determinants of Risk for Early-Onset Colorectal Cancer. Jnci Cancer Spectrum. 5: pkab029. PMID 34041438 DOI: 10.1093/jncics/pkab029 |
0.335 |
|
| 2021 |
Pham NA, Radulovich N, Ibrahimov E, Martins-Filho SN, Li Q, Pintilie M, Weiss J, Raghavan V, Cabanero M, Denroche RE, Wilson JM, Metran-Nascente C, Borgida A, Hutchinson S, Dodd A, ... ... Gallinger S, et al. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. Scientific Reports. 11: 10619. PMID 34011980 DOI: 10.1038/s41598-021-90049-1 |
0.3 |
|
| 2021 |
Kim SR, Tone A, Kim RH, Cesari M, Clarke BA, Eiriksson L, Hart TL, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, et al. Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer. Cancer. PMID 33983630 DOI: 10.1002/cncr.33625 |
0.333 |
|
| 2021 |
Hua X, Dai JY, Lindström S, Harrison TA, Lin Y, Alberts SR, Alwers E, Berndt SI, Brenner H, Buchanan DD, Campbell PT, Casey G, Chang-Claude J, Gallinger S, Giles GG, et al. Genetically predicted circulating C-reactive protein concentration and colorectal cancer survival: A Mendelian randomization consortium study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33972368 DOI: 10.1158/1055-9965.EPI-20-1848 |
0.304 |
|
| 2021 |
Jenkins MA, Buchanan DD, Lai J, Makalic E, Dite GS, Win AK, Clendenning M, Winship IM, Hayes RB, Huyghe JR, Peters U, Gallinger S, Marchand LL, Figueiredo JC, Pai RK, et al. Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal Cancer. Jnci Cancer Spectrum. 5: pkab022. PMID 33928216 DOI: 10.1093/jncics/pkab022 |
0.439 |
|
| 2021 |
Tsilidis KK, Papadimitriou N, Dimou N, Gill D, Lewis SJ, Martin RM, Murphy N, Markozannes G, Zuber V, Cross AJ, Burrows K, Lopez DS, Key TJ, Travis RC, Perez-Cornago A, ... ... Gallinger SJ, et al. Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study. The American Journal of Clinical Nutrition. PMID 33740060 DOI: 10.1093/ajcn/nqab003 |
0.355 |
|
| 2021 |
Roberts NJ, Grant RC, Gallinger S, Klein AP. Germline sequence analysis of RABL3 in a large series of pancreatic ductal adenocarcinoma patients reveals no evidence of deleterious variants. Genes, Chromosomes & Cancer. PMID 33724601 DOI: 10.1002/gcc.22947 |
0.413 |
|
| 2021 |
Huyghe JR, Harrison TA, Bien SA, Hampel H, Figueiredo JC, Schmit SL, Conti DV, Chen S, Qu C, Lin Y, Barfield R, Baron JA, Cross AJ, Diergaarde B, Duggan D, ... ... Gallinger SJ, et al. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. PMID 33632709 DOI: 10.1136/gutjnl-2020-321534 |
0.346 |
|
| 2021 |
Luchini C, Grant RC, Scarpa A, Gallinger S. Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different? Gut. PMID 33468535 DOI: 10.1136/gutjnl-2020-323805 |
0.354 |
|
| 2021 |
Georgeson P, Pope BJ, Rosty C, Clendenning M, Mahmood K, Joo JE, Walker R, Hutchinson RA, Preston S, Como J, Joseland S, Win AK, Macrae FA, Hopper JL, Mouradov D, ... ... Gallinger S, et al. Evaluating the utility of tumour mutational signatures for identifying hereditary colorectal cancer and polyposis syndrome carriers. Gut. PMID 33414168 DOI: 10.1136/gutjnl-2019-320462 |
0.4 |
|
| 2020 |
Jarvik GP, Wang X, Fontanillas P, Kim E, Chanprasert S, Gordon AS, Bastarache L, Kowdley KV, Harrison T, Rosenthal EA, Stanaway IB, Bézieau S, Weinstein SJ, Newcomb PA, Casey G, ... ... Gallinger SJ, et al. Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis. Hgg Advances. 1: 100010. PMID 35047832 DOI: 10.1016/j.xhgg.2020.100010 |
0.307 |
|
| 2020 |
Bull CJ, Bell JA, Murphy N, Sanderson E, Davey Smith G, Timpson NJ, Banbury BL, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Casey G, ... ... Gallinger SJ, et al. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. Bmc Medicine. 18: 396. PMID 33327948 DOI: 10.1186/s12916-020-01855-9 |
0.341 |
|
| 2020 |
Nounu A, Greenhough A, Heesom KJ, Richmond RC, Zheng J, Weinstein SJ, Albanes D, Baron JA, Hopper JL, Figueiredo JC, Newcomb PA, Lindor NM, Casey G, Platz EA, Le Marchand L, ... ... Gallinger S, et al. A combined proteomics and Mendelian randomization approach to investigate the effects of aspirin-targeted proteins on colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33318029 DOI: 10.1158/1055-9965.EPI-20-1176 |
0.319 |
|
| 2020 |
Kim SR, Tone A, Kim R, Cesari M, Clarke B, Eiriksson L, Hart T, Aronson M, Holter S, Lytwyn A, Maganti M, Oldfield L, Gallinger S, Bernardini MQ, Oza AM, et al. Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. PMID 33082239 DOI: 10.1136/ijgc-2020-001927 |
0.31 |
|
| 2020 |
Guo X, Lin W, Wen W, Huyghe J, Bien S, Cai Q, Harrison T, Chen Z, Qu C, Bao J, Long J, Yuan Y, Wang F, Bai M, Abecasis GR, ... ... Gallinger SJ, et al. Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects. Gastroenterology. PMID 33058866 DOI: 10.1053/j.gastro.2020.08.062 |
0.332 |
|
| 2020 |
Labadie JD, Harrison TA, Banbury B, Amtay EL, Bernd S, Brenner H, Buchanan DD, Campbell PT, Cao Y, Chan AT, Chang-Claude J, English D, Figueiredo JC, Gallinger SJ, Giles GG, et al. Postmenopausal Hormone Therapy and Colorectal Cancer Risk by Molecularly Defined Subtypes and Tumor Location. Jnci Cancer Spectrum. 4: pkaa042. PMID 32923935 DOI: 10.1093/Jncics/Pkaa042 |
0.308 |
|
| 2020 |
Burke CA, Dekker E, Lynch P, Samadder NJ, Balaguer F, Hüneburg R, Burn J, Castells A, Gallinger S, Lim R, Stoffel EM, Gupta S, Henderson A, Kallenberg FG, Kanth P, et al. Eflornithine plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis. The New England Journal of Medicine. 383: 1028-1039. PMID 32905675 DOI: 10.1056/Nejmoa1916063 |
0.642 |
|
| 2020 |
Jamal S, Sheppard AJ, Cotterchio M, Gallinger S. Association between known risk factors and colorectal cancer risk in Indigenous people participating in the Ontario Familial Colon Cancer Registry. Current Oncology (Toronto, Ont.). 27: e395-e398. PMID 32905327 DOI: 10.3747/co.27.6039 |
0.396 |
|
| 2020 |
Seyed Khoei N, Jenab M, Murphy N, Banbury BL, Carreras-Torres R, Viallon V, Kühn T, Bueno-de-Mesquita B, Aleksandrova K, Cross AJ, Weiderpass E, Stepien M, Bulmer A, Tjønneland A, Boutron-Ruault MC, ... ... Gallinger S, et al. Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses. Bmc Medicine. 18: 229. PMID 32878631 DOI: 10.1186/S12916-020-01703-W |
0.358 |
|
| 2020 |
Wang Y, Park JYP, Pacis A, Denroche RE, Jang GH, Zhang A, Cuggia A, Domecq C, Monlong J, Raitses-Gurevich M, Grant RC, Borgida A, Holter S, Stossel C, Bu S, ... ... Gallinger S, et al. A preclinical trial and molecularly-annotated patient cohort identify predictive biomarkers in homologous recombination deficient pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32816949 DOI: 10.1158/1078-0432.CCR-20-1439 |
0.307 |
|
| 2020 |
Zaidi SH, Harrison TA, Phipps AI, Steinfelder R, Trinh QM, Qu C, Banbury BL, Georgeson P, Grasso CS, Giannakis M, Adams JB, Alwers E, Amitay EL, Barfield RT, Berndt SI, ... ... Gallinger S, et al. Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival. Nature Communications. 11: 3644. PMID 32686686 DOI: 10.1038/S41467-020-17386-Z |
0.366 |
|
| 2020 |
Topham JT, Titmuss E, Pleasance ED, Williamson LM, Karasinska JM, Culibrk L, Lee MK, Mendis S, Denroche RE, Jang GH, Kalloger SE, Wong HL, Moore RA, Mungall AJ, O'Kane GM, ... ... Gallinger S, et al. Endogenous retrovirus transcript levels are associated with immunogenic signatures in multiple metastatic cancer types. Molecular Cancer Therapeutics. PMID 32518206 DOI: 10.1158/1535-7163.Mct-20-0094 |
0.335 |
|
| 2020 |
Xie IY, Gallinger S. The genomic landscape of recurrent pancreatic cancer is modified by treatment. Nature Reviews. Gastroenterology & Hepatology. PMID 32483355 DOI: 10.1038/s41575-020-0321-9 |
0.304 |
|
| 2020 |
Gupta S, Bharti B, Ahnen DJ, Buchanan DD, Cheng IC, Cotterchio M, Figueiredo JC, Gallinger SJ, Haile RW, Jenkins MA, Lindor NM, Macrae FA, Le Marchand L, Newcomb PA, Thibodeau SN, et al. Potential impact of family history-based screening guidelines on the detection of early-onset colorectal cancer. Cancer. PMID 32307706 DOI: 10.1002/Cncr.32851 |
0.342 |
|
| 2020 |
Gemechu SD, van Vliet CM, Win AK, Figueiredo JC, Le Marchand L, Gallinger S, Newcomb PA, Hopper JL, Lindor NM, Jenkins MA, Dowty JG. Do the risks of Lynch syndrome-related cancers depend on the parent of origin of the mutation? Familial Cancer. PMID 32107660 DOI: 10.1007/S10689-020-00167-4 |
0.38 |
|
| 2020 |
Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Martin RM, Lewis SJ, Kazmi N, Robinson TM, Albanes D, Aleksandrova K, Berndt SI, Timothy Bishop D, Brenner H, Buchanan DD, Bueno-de-Mesquita B, ... ... Gallinger SJ, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nature Communications. 11: 597. PMID 32001714 DOI: 10.1038/S41467-020-14389-8 |
0.327 |
|
| 2020 |
Zheng Y, Hua X, Win AK, MacInnis RJ, Gallinger S, Le Marchand L, Lindor NM, Baron JA, Hopper JL, Dowty JG, Antoniou AC, Zheng J, Jenkins MA, Newcomb PA. A new comprehensive colorectal cancer risk prediction model incorporating family history, personal characteristics, and environmental factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31932410 DOI: 10.1158/1055-9965.Epi-19-0929 |
0.324 |
|
| 2020 |
Zhong J, Jermusyk A, Wu L, Hoskins JW, Collins I, Mocci E, Zhang M, Song L, Chung CC, Zhang T, Xiao W, Albanes D, Andreotti G, Arslan AA, Babic A, ... ... Gallinger S, et al. A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Journal of the National Cancer Institute. PMID 31917448 DOI: 10.1093/Jnci/Djz246 |
0.334 |
|
| 2020 |
Guelpen BV, Gylling B, Harlid S, Winkvist A, Brenner H, Buchanan DD, Campbell PT, Chan AT, Chang-Claude J, Gallinger SJ, Giles GG, Gunter MJ, Hoffmeister M, Hsu L, Jenkins MA, et al. Abstract 2355: Folate and folic acid intake in relation to molecular subtypes of colorectal cancer; a pooled analysis of 7542 cases Epidemiology. 80: 2355-2355. DOI: 10.1158/1538-7445.Am2020-2355 |
0.382 |
|
| 2020 |
Labadie J, Harrison T, Buchanan D, Campbell P, Chan A, Gallinger S, Giles G, Gunter M, Hoffmeister M, Jenkins M, Ogino S, Slattery M, Guelpen BV, Peters U, Newcomb P. Postmenopausal Hormone Therapy Is Primarily Associated with Reduced Risk of Colorectal Cancer Arising through the Adenoma-Carcinoma Pathway Cancer Epidemiology and Prevention Biomarkers. 29: 693-693. DOI: 10.1158/1055-9965.Epi-20-0058 |
0.335 |
|
| 2019 |
Archambault AN, Su YR, Jeon J, Thomas M, Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse EF, Zauber AG, Duggan D, Holowatyj AN, Huyghe JR, Brenner H, ... ... Gallinger SJ, et al. Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer. Gastroenterology. PMID 31866242 DOI: 10.1053/J.Gastro.2019.12.012 |
0.385 |
|
| 2019 |
Dashti SG, Li WY, Buchanan DD, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Hardikar S, Hua X, Thibodeau SN, Figueiredo JC, Casey G, Haile RW, Gallinger S, et al. Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. British Journal of Cancer. PMID 31551580 DOI: 10.1038/S41416-019-0580-9 |
0.337 |
|
| 2019 |
McGarragle KM, Hare C, Holter S, Facey DA, McShane K, Gallinger S, Hart TL. Examining intrafamilial communication of colorectal cancer risk status to family members and kin responses to colonoscopy: a qualitative study. Hereditary Cancer in Clinical Practice. 17: 16. PMID 31391872 DOI: 10.1186/s13053-019-0114-8 |
0.371 |
|
| 2019 |
Dominguez-Valentin M, Sampson JR, Seppälä TT, Ten Broeke SW, Plazzer JP, Nakken S, Engel C, Aretz S, Jenkins MA, Sunde L, Bernstein I, Capella G, Balaguer F, Thomas H, Evans DG, ... ... Gallinger S, et al. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 31337882 DOI: 10.1038/S41436-019-0596-9 |
0.365 |
|
| 2019 |
Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, ... ... Gallinger S, et al. Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. Human Genetics. PMID 31254090 DOI: 10.1007/S00439-019-02030-8 |
0.324 |
|
| 2019 |
De Rubeis V, Cotterchio M, Smith BT, Griffith LE, Borgida A, Gallinger S, Cleary S, Anderson LN. Trajectories of body mass index, from adolescence to older adulthood, and pancreatic cancer risk; a population-based case-control study in Ontario, Canada. Cancer Causes & Control : Ccc. PMID 31230151 DOI: 10.1007/s10552-019-01197-9 |
0.305 |
|
| 2019 |
Pardini B, Corrado A, Paolicchi E, Cugliari G, Berndt SI, Bezieau S, Bien SA, Brenner H, Caan BJ, Campbell PT, Casey G, Chan AT, Chang-Claude J, Cotterchio M, Gala M, ... Gallinger SJ, et al. DNA repair and cancer in colon and rectum: novel players in genetic susceptibility. International Journal of Cancer. PMID 31209889 DOI: 10.1002/Ijc.32516 |
0.412 |
|
| 2019 |
Law PJ, Timofeeva M, Fernandez-Rozadilla C, Broderick P, Studd J, Fernandez-Tajes J, Farrington S, Svinti V, Palles C, Orlando G, Sud A, Holroyd A, Penegar S, Theodoratou E, Vaughan-Shaw P, ... ... Gallinger S, et al. Association analyses identify 31 new risk loci for colorectal cancer susceptibility. Nature Communications. 10: 2154. PMID 31089142 DOI: 10.1038/S41467-019-09775-W |
0.34 |
|
| 2019 |
Chen F, Childs EJ, Mocci E, Bracci PM, Gallinger S, Li D, Neale RE, Olson SH, Scelo G, Bamlet WR, Blackford AL, Borges M, Brennan P, Chaffee KG, Duggal P, et al. Analysis of heritability and genetic architecture of Pancreatic Cancer: A PanC4 Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31015203 DOI: 10.1158/1055-9965.Epi-18-1235 |
0.337 |
|
| 2019 |
Esplen MJ, Harrington S, Leung YW, Aronson M, Rothenmund H, Semotiuk K, Wong J, Gallinger S, Dicks E, McLaughlin J. Telephone versus in-person colorectal cancer risk and screening intervention for first-degree relatives: A randomized controlled trial. Cancer. PMID 30861097 DOI: 10.1002/cncr.32032 |
0.321 |
|
| 2019 |
Bien SA, Su YR, Conti DV, Harrison TA, Qu C, Guo X, Lu Y, Albanes D, Auer PL, Banbury BL, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Caan BJ, ... ... Gallinger S, et al. Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer. Human Genetics. PMID 30820706 DOI: 10.1007/S00439-019-01989-8 |
0.341 |
|
| 2019 |
Lucien F, Lac V, Billadeau DD, Borgida A, Gallinger S, Leong HS. Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases. Oncotarget. 10: 1045-1055. PMID 30800217 DOI: 10.18632/Oncotarget.26620 |
0.309 |
|
| 2019 |
Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M, Wilson G, Grant RC, Merico D, Lungu I, Bartlett JMS, Chadwick D, Liang SB, Eagles J, Mbabaali F, ... ... Gallinger S, et al. Integration of Genomic and Transcriptional Features in Pancreatic Cancer Reveals Increased Cell Cycle Progression in Metastases. Cancer Cell. PMID 30686769 DOI: 10.1016/J.Ccell.2018.12.010 |
0.303 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Gallinger SJ, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.343 |
|
| 2019 |
Shuen AY, Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB, Mandel A, Zhang C, Zhukova N, Alharbi M, Bernstein M, Bowers DC, Carroll S, Cole KA, Constantini S, ... ... Gallinger S, et al. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1800474. PMID 30608896 DOI: 10.1200/Jco.18.00474 |
0.326 |
|
| 2019 |
Zaidi S, Phipps A, Harrison T, Grasso C, Steinfelder R, Trinh Q, Connolly C, Banbury B, Rafikova A, Hofer P, Brezina S, Giannakis M, Mu XJ, Quist M, Fuchs C, ... ... Gallinger S, et al. Abstract 1224: Deep targeted tumor sequencing of colorectal cancer cases to study associations of molecular subtypes with clinical, genetic, and lifestyle risk factors Cancer Research. 78: 1224-1224. DOI: 10.1158/1538-7445.Am2018-1224 |
0.412 |
|
| 2019 |
Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Miller JK, O’Kane GM, Fischer SE, Wilson J, Notta F, Knox JJ, Gallinger S. Comparison of primary and metastatic pancreatic cancer by integration of clinical, pathologic, genomic and transcriptional features Hpb. 21. DOI: 10.1016/J.Hpb.2019.03.009 |
0.379 |
|
| 2018 |
Ten Broeke SW, van der Klift HM, Tops CMJ, Aretz S, Bernstein I, Buchanan DD, de la Chapelle A, Capella G, Clendenning M, Engel C, Gallinger S, Gomez Garcia E, Figueiredo JC, Haile R, Hampel HL, et al. Cancer Risks for PMS2-Associated Lynch Syndrome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018784777. PMID 30161022 DOI: 10.1200/JCO.2018.78.4777 |
0.431 |
|
| 2018 |
Theodoratou E, Farrington SM, Timofeeva M, Din FV, Svinti V, Tenesa A, Liu T, Lindblom A, Gallinger S, Campbell H, Dunlop MG. Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome. British Journal of Cancer. PMID 30135471 DOI: 10.1038/s41416-018-0117-7 |
0.324 |
|
| 2018 |
Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, ... ... Gallinger SJ, et al. Novel Common Genetic Susceptibility Loci for Colorectal Cancer. Journal of the National Cancer Institute. PMID 29917119 DOI: 10.1093/Jnci/Djy099 |
0.388 |
|
| 2018 |
Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, Peterson SK, You YN, Buchanan DD, Figueiredo JC, Campbell PT, Gallinger S, Newcomb PA, Potter JD, Lindor NM, et al. Physical activity and the risk of colorectal cancer in Lynch syndrome. International Journal of Cancer. PMID 29904935 DOI: 10.1002/Ijc.31611 |
0.386 |
|
| 2018 |
Tiriac H, Belleau P, Engle DD, Plenker D, Deschênes A, Somerville T, Froeling FEM, Burkhart RA, Denroche RE, Jang GH, Miyabayashi K, Young CM, Patel H, Ma M, LaComb JF, ... ... Gallinger S, et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discovery. PMID 29853643 DOI: 10.1158/2159-8290.Cd-18-0349 |
0.326 |
|
| 2018 |
Neumeyer S, Banbury BL, Arndt V, Berndt SI, Bezieau S, Bien SA, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Casey G, Chan AT, Chanock SJ, Dai JY, Gallinger S, et al. Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer. British Journal of Cancer. PMID 29795306 DOI: 10.1038/S41416-018-0108-8 |
0.333 |
|
| 2018 |
Pande M, Joon A, Brewster AM, Chen WV, Hopper JL, Eng C, Shete S, Casey G, Schumacher F, Lin Y, Harrison TA, White E, Ahsan H, Andrulis IL, Whittemore AS, ... ... Gallinger S, et al. Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. Plos One. 13: e0196245. PMID 29698419 DOI: 10.1371/Journal.Pone.0196245 |
0.343 |
|
| 2018 |
Tamura K, Yu J, Hata T, Suenaga M, Shindo K, Abe T, MacGregor-Das A, Borges M, Wolfgang CL, Weiss MJ, He J, Canto MI, Petersen GM, Gallinger S, Syngal S, et al. Mutations in the pancreatic secretory enzymes and are associated with pancreatic cancer. Proceedings of the National Academy of Sciences of the United States of America. PMID 29669919 DOI: 10.1073/Pnas.1720588115 |
0.334 |
|
| 2018 |
Jenkins MA, Win AK, Templeton AS, Angelakos MS, Buchanan DD, Cotterchio M, Figueiredo JC, Thibodeau SN, Baron JA, Potter JD, Hopper JL, Casey G, Gallinger S, Le Marchand L, Lindor NM, et al. Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). International Journal of Epidemiology. PMID 29490034 DOI: 10.1093/Ije/Dyy006 |
0.351 |
|
| 2018 |
Grant RC, Holter S, Borgida A, Dhani NC, Hedley DW, Knox JJ, Akbari MR, Zogopoulos G, Gallinger S. Comparison of Practice Guidelines, BRCAPRO, and Genetic Counselor Estimates to Identify Germline BRCA1 and BRCA2 Mutations in Pancreatic Cancer. Journal of Genetic Counseling. PMID 29441441 DOI: 10.1007/s10897-018-0212-1 |
0.328 |
|
| 2018 |
Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, ... ... Gallinger S, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications. 9: 556. PMID 29422604 DOI: 10.1038/S41467-018-02942-5 |
0.323 |
|
| 2018 |
Petersen PS, Su Y, Berndt SI, Bien SA, Brenner H, Casey G, Chan AT, Chang-Claude J, Figueiredo JC, Gallinger SJ, Haile RW, Harrison TA, Hoffmeister M, Jenkins MA, Joshi AD, et al. Abstract 5268: Interactions between genetic predictors of gene expression and dietary factors associated with risk of colorectal cancer Cancer Research. 78: 5268-5268. DOI: 10.1158/1538-7445.Am2018-5268 |
0.322 |
|
| 2018 |
Bacher J, Halberg R, Ward P, Udho E, Murphy K, Uhr M, Dubeau L, Pettersson J, Storts D, Gallinger S, Buchanan D, Jenkins M, Lindor N, Eshleman J. Development of a pan-cancer biomarker panel for improved detection of MSI across all cancer types Annals of Oncology. 29: viii27-viii28. DOI: 10.1093/Annonc/Mdy269.088 |
0.439 |
|
| 2017 |
Bien SA, Auer PL, Harrison TA, Qu C, Connolly CM, Greenside PG, Chen S, Berndt SI, Bézieau S, Kang HM, Huyghe J, Brenner H, Casey G, Chan AT, Hopper JL, ... ... Gallinger S, et al. Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data. Plos One. 12: e0186518. PMID 29161273 DOI: 10.1371/Journal.Pone.0186518 |
0.301 |
|
| 2017 |
O'Kane GM, Connor AA, Gallinger S. Characterization, Detection, and Treatment Approaches for Homologous Recombination Deficiency in Cancer. Trends in Molecular Medicine. PMID 29133135 DOI: 10.1016/j.molmed.2017.10.007 |
0.313 |
|
| 2017 |
Grant RC, Denroche RE, Borgida A, Virtanen C, Cook N, Smith AL, Connor AA, Wilson JM, Peterson G, Roberts NJ, Klein AP, Grimmond SM, Biankin A, Cleary S, Moore M, ... ... Gallinger S, et al. Exome-Wide Association Study Of Pancreatic Cancer Risk. Gastroenterology. PMID 29074453 DOI: 10.1053/j.gastro.2017.10.015 |
0.409 |
|
| 2017 |
Tanskanen T, van den Berg L, Välimäki N, Aavikko M, Ness-Jensen E, Hveem K, Wettergren Y, Bexe Lindskog E, Tõnisson N, Metspalu A, Silander K, Orlando G, Law PJ, Tuupanen S, Gylfe AE, ... ... Gallinger S, et al. Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci. International Journal of Cancer. PMID 28960316 DOI: 10.1002/Ijc.31076 |
0.414 |
|
| 2017 |
DeRycke MS, Gunawardena S, Balcom JR, Pickart AM, Waltman LA, French AJ, McDonnell S, Riska SM, Fogarty ZC, Larson MC, Middha S, Eckloff BW, Asmann YW, Ferber MJ, Haile RW, ... Gallinger S, et al. Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. Molecular Genetics & Genomic Medicine. 5: 553-569. PMID 28944238 DOI: 10.1002/Mgg3.317 |
0.405 |
|
| 2017 |
Kocarnik JM, Hua X, Hardikar S, Robinson J, Lindor NM, Win AK, Hopper JL, Figueiredo JC, Potter JD, Campbell PT, Gallinger S, Cotterchio M, Adams SV, Cohen SA, Phipps AI, et al. Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry. Cancer. PMID 28841225 DOI: 10.1002/Cncr.30932 |
0.303 |
|
| 2017 |
May-Wilson S, Sud A, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen UA, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Eriksson JG, Rissanen H, Knekt P, ... ... Gallinger S, et al. Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian randomisation analysis. European Journal of Cancer (Oxford, England : 1990). 84: 228-238. PMID 28829991 DOI: 10.1016/J.Ejca.2017.07.034 |
0.304 |
|
| 2017 |
Golan T, Stossel C, Schvimer M, Atias D, Halperin S, Buzhor E, Raitses-Gurevich M, Cohen K, Pri-Chen S, Wilson J, Denroche RE, Lungu I, Bartlett JMS, Mbabaali F, Yarden Y, ... ... Gallinger S, et al. Pancreatic cancer ascites xenograft-an expeditious model mirroring advanced therapeutic resistant disease. Oncotarget. PMID 28489577 DOI: 10.18632/Oncotarget.17253 |
0.356 |
|
| 2017 |
Golan T, Raitses-Gurevich M, Kelley RK, Bocobo AG, Borgida A, Shroff RT, Holter S, Gallinger S, Ahn DH, Aderka D, Apurva J, Bekaii-Saab T, Friedman E, Javle M. Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective Study. The Oncologist. PMID 28487467 DOI: 10.1634/theoncologist.2016-0415 |
0.325 |
|
| 2017 |
Golan T, Sella T, O'Reilly EM, Katz MH, Epelbaum R, Kelsen DP, Borgida A, Maynard H, Kindler H, Friedmen E, Javle M, Gallinger S. Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancer. British Journal of Cancer. PMID 28183138 DOI: 10.1038/bjc.2017.19 |
0.345 |
|
| 2017 |
Huyghe JR, Chen S, Kang HM, Harrison T, Berndt SI, Bézieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Gallinger SJ, Gruber SB, Gsur A, Hoffmeister M, Hudson T, et al. Abstract 1304: The contribution of rare and low-frequency variants to colorectal cancer heritability Epidemiology. 77: 1304-1304. DOI: 10.1158/1538-7445.Am2017-1304 |
0.347 |
|
| 2016 |
Lohse I, Kumareswaran R, Cao P, Pitcher B, Gallinger S, Bristow RG, Hedley DW. Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts. Plos One. 11: e0167272. PMID 28033382 DOI: 10.1371/Journal.Pone.0167272 |
0.305 |
|
| 2016 |
Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Parry S, Casey G, Haile RW, Gallinger S, Le Marchand L, Thibodeau SN, et al. Alcohol Consumption and the Risk of Colorectal Cancer in Mismatch Repair Gene Mutation Carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27811119 DOI: 10.1158/1055-9965.Epi-16-0496 |
0.359 |
|
| 2016 |
Win AK, Jenkins MA, Dowty JG, Antoniou AC, Lee A, Giles GG, Buchanan DD, Clendenning M, Rosty C, Ahnen DJ, Thibodeau SN, Casey G, Gallinger S, Le Marchand L, Haile RW, et al. Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27799157 DOI: 10.1158/1055-9965.Epi-16-0693 |
0.372 |
|
| 2016 |
Notta F, Chan-Seng-Yue M, Lemire M, Li Y, Wilson GW, Connor AA, Denroche RE, Liang SB, Brown AM, Kim JC, Wang T, Simpson JT, Beck T, Borgida A, Buchner N, ... ... Gallinger S, et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature. PMID 27732578 DOI: 10.1038/Nature19823 |
0.393 |
|
| 2016 |
Wang T, Notta F, Navab R, Joseph J, Ibrahimov E, Xu J, Zhu CQ, Borgida A, Gallinger S, Tsao MS. Senescent Carcinoma-associated Fibroblasts Upregulate IL8 to Enhance Pro-metastatic Phenotypes. Molecular Cancer Research : McR. PMID 27678171 DOI: 10.1158/1541-7786.Mcr-16-0192 |
0.336 |
|
| 2016 |
Zhang M, Wang Z, Obazee O, Jia J, Childs EJ, Hoskins J, Figlioli G, Mocci E, Collins I, Chung CC, Hautman C, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, ... ... Gallinger S, et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Oncotarget. PMID 27579533 DOI: 10.18632/Oncotarget.11041 |
0.313 |
|
| 2016 |
Karami S, Han Y, Pande M, Cheng I, Rudd J, Pierce BL, Nutter EL, Schumacher FR, Kote-Jarai Z, Lindstrom S, Witte JS, Fang S, Han J, Kraft P, Hunter DJ, ... ... Gallinger SJ, et al. Telomere structure and maintenance gene variants and risk of five cancer types. International Journal of Cancer. PMID 27459707 DOI: 10.1002/Ijc.30288 |
0.316 |
|
| 2016 |
Jarvis D, Mitchell JS, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen UA, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Kaprio J, Eriksson JG, Rissanen H, ... ... Gallinger S, et al. Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer. British Journal of Cancer. PMID 27336604 DOI: 10.1038/Bjc.2016.188 |
0.468 |
|
| 2016 |
Shang J, Reece JC, Buchanan DD, Giles GG, Figueiredo JC, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK. Cholecystectomy and the risk of colorectal cancer by tumor mismatch repair deficiency status. International Journal of Colorectal Disease. PMID 27286977 DOI: 10.1007/S00384-016-2615-5 |
0.407 |
|
| 2016 |
Childs EJ, Chaffee KG, Gallinger S, Syngal S, Schwartz AG, Cote ML, Bondy ML, Hruban RH, Chanock SJ, Hoover RN, Fuchs CS, Rider DN, Amundadottir LT, Stolzenberg-Solomon R, Wolpin BM, et al. Association of common susceptibility variants of pancreatic cancer in higher risk patients: A PACGENE study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197284 DOI: 10.1158/1055-9965.Epi-15-1217 |
0.409 |
|
| 2016 |
Win AK, Reece JC, Dowty JG, Buchanan DD, Clendenning M, Rosty C, Southey MC, Young JP, Cleary SP, Kim H, Cotterchio M, Macrae FA, Tucker KM, Baron JA, Burnett T, ... ... Gallinger S, et al. Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. International Journal of Cancer. PMID 27194394 DOI: 10.1002/Ijc.30197 |
0.416 |
|
| 2016 |
Jayasekara H, Reece JC, Buchanan DD, Rosty C, Dashti SG, Ouakrim DA, Winship IM, Macrae FA, Boussioutas A, Giles GG, Ahnen DJ, Lowery J, Casey G, Haile RW, Gallinger S, et al. Risk factors for metachronous colorectal cancer following a primary colorectal cancer: A prospective cohort study. International Journal of Cancer. PMID 27098183 DOI: 10.1002/Ijc.30153 |
0.393 |
|
| 2016 |
Lujan-Barroso L, Zhang W, Olson SH, Gao YT, Yu H, Baghurst PA, Bracci PM, Bueno-de-Mesquita B, Foretová L, Gallinger S, Holcatova I, Janout V, Ji BT, Kurtz RC, La Vecchia C, et al. Menstrual and Reproductive Factors, Hormone Use, and Risk of Pancreatic Cancer: Analysis From the International Pancreatic Cancer Case-Control Consortium (PanC4). Pancreas. PMID 27088489 DOI: 10.1097/Mpa.0000000000000635 |
0.331 |
|
| 2016 |
Lu C, Thoeni C, Connor A, Kawabe H, Gallinger S, Rotin D. Intestinal knockout of Nedd4 enhances growth of Apc(min) tumors. Oncogene. PMID 27086928 DOI: 10.1038/Onc.2016.125 |
0.317 |
|
| 2016 |
Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Macrae FA, Boussioutas A, Parry S, Figueiredo JC, Levine AJ, Ahnen DJ, ... ... Gallinger S, et al. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. International Journal of Epidemiology. PMID 27063605 DOI: 10.1093/Ije/Dyw036 |
0.353 |
|
| 2016 |
Wei AC, Coburn NG, Devitt KS, Serrano PE, Moulton CA, Cleary SP, Law C, Moore MJ, Gallinger S. Survival Following Resection of Intra- and Extra-Hepatic Metastases from Colorectal Cancer: A Phase II Trial. Annals of Surgical Oncology. PMID 27027312 DOI: 10.1245/s10434-016-5189-0 |
0.352 |
|
| 2016 |
Wang M, Aldubayan S, Connor AA, Wong B, Mcnamara K, Khan T, Semotiuk K, Khalouei S, Holter S, Aronson M, Cohen Z, Gallinger S, Charames G, Pollett A, Lerner-Ellis J. Genetic testing for Lynch syndrome in the province of Ontario. Cancer. PMID 27019099 DOI: 10.1002/Cncr.29950 |
0.324 |
|
| 2016 |
Orlando G, Law PJ, Palin K, Tuupanen S, Gylfe A, Hänninen U, Cajuso T, Tanskanen T, Kondelin J, Kaasinen E, Sarin AP, Kaprio J, Eriksson JG, Rissanen H, Knekt P, ... ... Gallinger S, et al. Variation at 2q35 (PNKD and TMBIM1) influences colorectal cancer risk and identifies a pleiotropic effect with inflammatory bowel disease. Human Molecular Genetics. PMID 27005424 DOI: 10.1093/Hmg/Ddw087 |
0.414 |
|
| 2016 |
Rosty C, Clendenning M, Walsh MD, Eriksen SV, Southey MC, Winship IM, Macrae FA, Boussioutas A, Poplawski NK, Parry S, Arnold J, Young JP, Casey G, Haile RW, Gallinger S, et al. Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort. Bmj Open. 6: e010293. PMID 26895986 DOI: 10.1136/Bmjopen-2015-010293 |
0.349 |
|
| 2016 |
Savio AJ, Daftary D, Dicks E, Buchanan DD, Parfrey PS, Young JP, Weisenberger D, Green RC, Gallinger S, McLaughlin JR, Knight JA, Bapat B. Promoter methylation of ITF2, but not APC, is associated with microsatellite instability in two populations of colorectal cancer patients. Bmc Cancer. 16: 113. PMID 26884349 DOI: 10.1186/S12885-016-2149-9 |
0.37 |
|
| 2016 |
Radulovich N, Ibrahimov E, Holt C, Raghavan V, Zhao T, Denroch R, Pham N, Gallinger S, Pintilie M, Stein L, McPherson J, Muthuswamy L, Tsao MS. Abstract B31: Establishment and molecular characterization of patient-derived tumor xenografts from resected tumors or ascites fluids of patients with pancreatic/ampullary/bile duct carcinomas Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B31 |
0.443 |
|
| 2016 |
Zaidi SH, Grasso C, Mu J, Shinbrot E, Giannakis M, Connolly C, Borozan I, Brenner H, Campbell P, Chan A, Chang-Claude J, Du M, Ferretti V, French A, Fuchs C, ... Gallinger S, et al. Abstract 5221: Linking the molecular profile of colorectal tumors to germline genetic and environmental risk factors Cancer Research. 76: 5221-5221. DOI: 10.1158/1538-7445.Am2016-5221 |
0.374 |
|
| 2016 |
Bien SA, Harrison TA, Auer PL, Qu F, Huyghe J, Banbury B, Greenside P, Abecasis GR, Berndt SI, Bézieau S, Brenner H, Casey G, Chan AT, Chang-Claude J, Chen S, ... ... Gallinger SJ, et al. Abstract 4489: Using functional data from Roadmap Epigenomics to inform analysis of rare variants linked to gene expression in a large colorectal cancer study Cancer Research. 76: 4489-4489. DOI: 10.1158/1538-7445.Am2016-4489 |
0.39 |
|
| 2015 |
Connor AA, McNamara K, Al-Sukhni E, Diskin J, Chan D, Ash C, Lowes LE, Allan AL, Zogopoulos G, Moulton CA, Gallinger S. Central, But Not Peripheral, Circulating Tumor Cells are Prognostic in Patients Undergoing Resection of Colorectal Cancer Liver Metastases. Annals of Surgical Oncology. PMID 26714949 DOI: 10.1245/s10434-015-5038-6 |
0.357 |
|
| 2015 |
Chau R, Jenkins MA, Buchanan DD, Ait Ouakrim D, Giles GG, Casey G, Gallinger S, Haile RW, Le Marchand L, Newcomb PA, Lindor NM, Hopper JL, Win AK. Determining the familial risk distribution of colorectal cancer: a data mining approach. Familial Cancer. PMID 26681340 DOI: 10.1007/S10689-015-9860-6 |
0.379 |
|
| 2015 |
Roberts NJ, Norris AL, Petersen GM, Bondy ML, Brand R, Gallinger S, Kurtz RC, Olson SH, Rustgi AK, Schwartz AG, Stoffel EM, Syngal S, Zogopoulos G, Ali SZ, Axilbund J, et al. Whole genome sequencing defines the genetic heterogeneity of familial pancreatic cancer. Cancer Discovery. PMID 26658419 DOI: 10.1158/2159-8290.Cd-15-0402 |
0.41 |
|
| 2015 |
McWilliams RR, Maisonneuve P, Bamlet WR, Petersen GM, Li D, Risch HA, Yu H, Fontham ET, Luckett B, ScD CB, Negri E, La Vecchia C, Talamini R, de Mesquita HB, Bracci P, ... Gallinger S, et al. Risk Factors for Early-Onset and Very-Early-Onset Pancreatic Adenocarcinoma: A Pancreatic Cancer Case-Control Consortium (PanC4) Analysis. Pancreas. PMID 26646264 DOI: 10.1097/Mpa.0000000000000392 |
0.314 |
|
| 2015 |
Cheng TH, Thompson D, Painter J, O'Mara T, Gorman M, Martin L, Palles C, Jones A, Buchanan DD, Ko Win A, Hopper J, Jenkins M, Lindor NM, Newcomb PA, Gallinger S, et al. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. Scientific Reports. 5: 17369. PMID 26621817 DOI: 10.1038/Srep17369 |
0.457 |
|
| 2015 |
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, ... ... Gallinger SJ, et al. Corrigendum: Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature Communications. 6: 8739. PMID 26498495 DOI: 10.1038/Ncomms9739 |
0.322 |
|
| 2015 |
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... ... Gallinger S, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279 |
0.324 |
|
| 2015 |
Lemire M, Qu C, Loo LW, Zaidi SH, Wang H, Berndt SI, Bézieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Du M, Edlund CK, Gallinger S, Haile RW, et al. A genome-wide association study for colorectal cancer identifies a risk locus in 14q23.1. Human Genetics. PMID 26404086 DOI: 10.1007/S00439-015-1598-6 |
0.341 |
|
| 2015 |
Connor AA, Gallinger S. Hereditary Pancreatic Cancer Syndromes. Surgical Oncology Clinics of North America. 24: 733-64. PMID 26363539 DOI: 10.1016/j.soc.2015.06.007 |
0.32 |
|
| 2015 |
Dhani NC, Serra S, Pintilie M, Schwock J, Xu J, Gallinger S, Hill RP, Hedley DW. Analysis of the intra- and intertumoral heterogeneity of hypoxia in pancreatic cancer patients receiving the nitroimidazole tracer pimonidazole. British Journal of Cancer. PMID 26325106 DOI: 10.1038/bjc.2015.284 |
0.328 |
|
| 2015 |
Al-Tassan NA, Whiffin N, Hosking FJ, Palles C, Farrington SM, Dobbins SE, Harris R, Gorman M, Tenesa A, Meyer BF, Wakil SM, Kinnersley B, Campbell H, Martin L, Smith CG, ... ... Gallinger S, et al. Erratum: A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Scientific Reports. 5: 12372. PMID 26237130 DOI: 10.1038/Srep12372 |
0.436 |
|
| 2015 |
Win AK, Reece JC, Buchanan DD, Clendenning M, Young JP, Cleary SP, Kim H, Cotterchio M, Dowty JG, MacInnis RJ, Tucker KM, Winship IM, Macrae FA, Burnett T, Le Marchand L, ... ... Gallinger S, et al. Risk of colorectal cancer for people with a mutation in both a MUTYH and a DNA mismatch repair gene. Familial Cancer. 14: 575-83. PMID 26202870 DOI: 10.1007/S10689-015-9824-X |
0.333 |
|
| 2015 |
Aronson M, Holter S, Semotiuk K, Winter L, Pollett A, Gallinger S, Cohen Z, Gryfe R. DNA Mismatch Repair Status Predicts Need for Future Colorectal Surgery for Metachronous Neoplasms in Young Individuals Undergoing Colorectal Cancer Resection. Diseases of the Colon and Rectum. 58: 645-52. PMID 26200678 DOI: 10.1097/Dcr.0000000000000391 |
0.754 |
|
| 2015 |
Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, ... ... Gallinger S, et al. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. Jama Oncology. 1: 23-32. PMID 26182300 DOI: 10.1001/jamaoncol.2014.168 |
0.379 |
|
| 2015 |
Lohse I, Borgida A, Cao P, Cheung M, Pintilie M, Bianco T, Holter S, Ibrahimov E, Kumareswaran R, Bristow RG, Tsao MS, Gallinger S, Hedley DW. BRCA1 and BRCA2 mutations sensitize to chemotherapy in patient-derived pancreatic cancer xenografts. British Journal of Cancer. 113: 425-32. PMID 26180923 DOI: 10.1038/bjc.2015.220 |
0.378 |
|
| 2015 |
Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, ... ... Gallinger SJ, et al. Genome-wide association study of colorectal cancer identifies six new susceptibility loci. Nature Communications. 6: 7138. PMID 26151821 DOI: 10.1038/Ncomms8138 |
0.393 |
|
| 2015 |
Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, et al. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome. Jama. 314: 61-71. PMID 26151267 DOI: 10.1001/Jama.2015.6789 |
0.331 |
|
| 2015 |
Ait Ouakrim D, Dashti SG, Chau R, Buchanan DD, Clendenning M, Rosty C, Winship IM, Young JP, Giles GG, Leggett B, Macrae FA, Ahnen DJ, Casey G, Gallinger S, Haile RW, et al. Aspirin, Ibuprofen, and the Risk of Colorectal Cancer in Lynch Syndrome. Journal of the National Cancer Institute. 107. PMID 26109217 DOI: 10.1093/Jnci/Djv170 |
0.414 |
|
| 2015 |
Yurgelun MB, Masciari S, Joshi VA, Mercado RC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA, Buchanan DD, Newcomb PA, Potter JD, Haile RW, Kucherlapati R, Syngal S. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. Jama Oncology. 1: 214-21. PMID 26086041 DOI: 10.1001/Jamaoncol.2015.0197 |
0.464 |
|
| 2015 |
Antill YC, Dowty JG, Win AK, Thompson T, Walsh MD, Cummings MC, Gallinger S, Lindor NM, Le Marchand L, Hopper JL, Newcomb PA, Haile RW, Church J, Tucker KM, Buchanan DD, et al. Lynch syndrome and cervical cancer. International Journal of Cancer. Journal International Du Cancer. PMID 26077226 DOI: 10.1002/Ijc.29641 |
0.421 |
|
| 2015 |
Khalili H, Gong J, Brenner H, Austin TR, Hutter CM, Baba Y, Baron JA, Berndt SI, Bézieau S, Caan B, Campbell PT, Chang-Claude J, Chanock SJ, Chen C, Hsu L, ... ... Gallinger S, et al. Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer. Carcinogenesis. PMID 26071399 DOI: 10.1093/Carcin/Bgv086 |
0.34 |
|
| 2015 |
Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Amundadottir LT, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Chanock SJ, ... ... Gallinger S, et al. Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk. Plos One. 10: e0129983. PMID 26039095 DOI: 10.1371/Journal.Pone.0129983 |
0.396 |
|
| 2015 |
Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, et al. Association between Body Mass Index and Mortality for Colorectal Cancer Survivors: Overall and by Tumor Molecular Phenotype. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26038390 DOI: 10.1158/1055-9965.Epi-15-0094 |
0.362 |
|
| 2015 |
Al-Tassan NA, Whiffin N, Hosking FJ, Palles C, Farrington SM, Dobbins SE, Harris R, Gorman M, Tenesa A, Meyer BF, Wakil SM, Kinnersley B, Campbell H, Martin L, Smith CG, ... ... Gallinger S, et al. A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer. Scientific Reports. 5: 10442. PMID 25990418 DOI: 10.1038/Srep10442 |
0.395 |
|
| 2015 |
Heath JA, Reece JC, Buchanan DD, Casey G, Durno CA, Gallinger S, Haile RW, Newcomb PA, Potter JD, Thibodeau SN, Le Marchand L, Lindor NM, Hopper JL, Jenkins MA, Win AK. Childhood cancers in families with and without Lynch syndrome. Familial Cancer. PMID 25963852 DOI: 10.1007/S10689-015-9810-3 |
0.387 |
|
| 2015 |
Cotterchio M, Lowcock E, Bider-Canfield Z, Lemire M, Greenwood C, Gallinger S, Hudson T. Association between Variants in Atopy-Related Immunologic Candidate Genes and Pancreatic Cancer Risk. Plos One. 10: e0125273. PMID 25945796 DOI: 10.1371/Journal.Pone.0125273 |
0.348 |
|
| 2015 |
Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, ... ... Gallinger S, et al. Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec. Current Oncology (Toronto, Ont.). 22: 113-21. PMID 25908910 DOI: 10.3747/co.22.2300 |
0.32 |
|
| 2015 |
Durno CA, Sherman PM, Aronson M, Malkin D, Hawkins C, Bakry D, Bouffet E, Gallinger S, Pollett A, Campbell B, Tabori U. Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome. European Journal of Cancer (Oxford, England : 1990). 51: 977-83. PMID 25883011 DOI: 10.1016/J.Ejca.2015.02.008 |
0.34 |
|
| 2015 |
Goodenberger ML, Thomas BC, Riegert-Johnson D, Boland CR, Plon SE, Clendenning M, Win AK, Senter L, Lipkin SM, Stadler ZK, Macrae FA, Lynch HT, Weitzel JN, de la Chapelle A, Syngal S, ... ... Gallinger S, et al. PMS2 monoallelic mutation carriers: the known unknown. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 25856668 DOI: 10.1038/Gim.2015.27 |
0.382 |
|
| 2015 |
Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Cotterchio M, Duell EJ, ... Gallinger S, et al. Vitamin D metabolic pathway genes and pancreatic cancer risk. Plos One. 10: e0117574. PMID 25799011 DOI: 10.1371/Journal.Pone.0117574 |
0.395 |
|
| 2015 |
Shlien A, Campbell BB, de Borja R, Alexandrov LB, Merico D, Wedge D, Van Loo P, Tarpey PS, Coupland P, Behjati S, Pollett A, Lipman T, Heidari A, Deshmukh S, Avitzur N, ... ... Gallinger S, et al. Combined hereditary and somatic mutations of replication error repair genes result in rapid onset of ultra-hypermutated cancers. Nature Genetics. 47: 257-62. PMID 25642631 DOI: 10.1038/Ng.3202 |
0.366 |
|
| 2015 |
Grant RC, Selander I, Connor AA, Selvarajah S, Borgida A, Briollais L, Petersen GM, Lerner-Ellis J, Holter S, Gallinger S. Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. Gastroenterology. 148: 556-64. PMID 25479140 DOI: 10.1053/j.gastro.2014.11.042 |
0.427 |
|
| 2015 |
Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, et al. BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 17: 569-77. PMID 25356972 DOI: 10.1038/Gim.2014.153 |
0.387 |
|
| 2015 |
Ananthakrishnan AN, Du M, Berndt SI, Brenner H, Caan BJ, Casey G, Chang-Claude J, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, et al. Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 198-205. PMID 25342387 DOI: 10.1158/1055-9965.Epi-14-0897 |
0.344 |
|
| 2015 |
Esplen MJ, Wong J, Aronson M, Butler K, Rothenmund H, Semotiuk K, Madlensky L, Way C, Dicks E, Green J, Gallinger S. Long-term psychosocial and behavioral adjustment in individuals receiving genetic test results in Lynch syndrome. Clinical Genetics. 87: 525-32. PMID 25297893 DOI: 10.1111/Cge.12509 |
0.309 |
|
| 2015 |
Win AK, Buchanan DD, Rosty C, MacInnis RJ, Dowty JG, Dite GS, Giles GG, Southey MC, Young JP, Clendenning M, Walsh MD, Walters RJ, Boussioutas A, Smyrk TC, Thibodeau SN, ... ... Gallinger S, et al. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut. 64: 101-10. PMID 24615377 DOI: 10.1136/Gutjnl-2013-306567 |
0.343 |
|
| 2014 |
Rosty C, Walsh MD, Lindor NM, Thibodeau SN, Mundt E, Gallinger S, Aronson M, Pollett A, Baron JA, Pearson S, Clendenning M, Walters RJ, Nagler BN, Crawford WJ, Young JP, et al. High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registry. Familial Cancer. 13: 573-82. PMID 25117503 DOI: 10.1007/S10689-014-9744-1 |
0.366 |
|
| 2014 |
Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M, Wilkens LR, Loo LW, Van Den Berg D, Kolonel LN, Henderson BE, Keku TO, Sandler RS, Signorello LB, Blot WJ, Newcomb PA, ... ... Gallinger S, et al. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A. Nature Communications. 5: 4613. PMID 25105248 DOI: 10.1038/Ncomms5613 |
0.311 |
|
| 2014 |
Ferguson SE, Aronson M, Pollett A, Eiriksson LR, Oza AM, Gallinger S, Lerner-Ellis J, Alvandi Z, Bernardini MQ, MacKay HJ, Mojtahedi G, Tone AA, Massey C, Clarke BA. Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing. Cancer. 120: 3932-9. PMID 25081409 DOI: 10.1002/cncr.28933 |
0.336 |
|
| 2014 |
Golan T, Kanji ZS, Epelbaum R, Devaud N, Dagan E, Holter S, Aderka D, Paluch-Shimon S, Kaufman B, Gershoni-Baruch R, Hedley D, Moore MJ, Friedman E, Gallinger S. Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers. British Journal of Cancer. 111: 1132-8. PMID 25072261 DOI: 10.1038/Bjc.2014.418 |
0.403 |
|
| 2014 |
Bosetti C, Rosato V, Li D, Silverman D, Petersen GM, Bracci PM, Neale RE, Muscat J, Anderson K, Gallinger S, Olson SH, Miller AB, Bas Bueno-de-Mesquita H, Scelo G, Janout V, et al. Diabetes, antidiabetic medications, and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 25: 2065-72. PMID 25057164 DOI: 10.1093/Annonc/Mdu276 |
0.399 |
|
| 2014 |
Chan N, Ali M, McCallum GP, Kumareswaran R, Koritzinsky M, Wouters BG, Wells PG, Gallinger S, Bristow RG. Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells. Molecular Cancer Research : McR. 12: 1407-15. PMID 25030372 DOI: 10.1158/1541-7786.Mcr-14-0246 |
0.305 |
|
| 2014 |
Schmit SL, Schumacher FR, Edlund CK, Conti DV, Raskin L, Lejbkowicz F, Pinchev M, Rennert HS, Jenkins MA, Hopper JL, Buchanan DD, Lindor NM, Le Marchand L, Gallinger S, Haile RW, et al. A novel colorectal cancer risk locus at 4q32.2 identified from an international genome-wide association study. Carcinogenesis. 35: 2512-9. PMID 25023989 DOI: 10.1093/Carcin/Bgu148 |
0.371 |
|
| 2014 |
Fehringer G, Gallinger S, Borgida A, Zhang LR, Adams L, Liu G, Hung RJ. The association of family history of cancer and medical history with pancreatic cancer risk. Pancreas. 43: 812-4. PMID 24921205 DOI: 10.1097/Mpa.0000000000000126 |
0.366 |
|
| 2014 |
Shiovitz S, Copeland WK, Passarelli MN, Burnett-Hartman AN, Grady WM, Potter JD, Gallinger S, Buchanan DD, Rosty C, Win AK, Jenkins M, Thibodeau SN, Haile R, Baron JA, Marchand LL, et al. Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer. British Journal of Cancer. 111: 598-602. PMID 24918813 DOI: 10.1038/Bjc.2014.309 |
0.501 |
|
| 2014 |
Figueiredo JC, Hsu L, Hutter CM, Lin Y, Campbell PT, Baron JA, Berndt SI, Jiao S, Casey G, Fortini B, Chan AT, Cotterchio M, Lemire M, Gallinger S, Harrison TA, et al. Genome-wide diet-gene interaction analyses for risk of colorectal cancer. Plos Genetics. 10: e1004228. PMID 24743840 DOI: 10.1371/Journal.Pgen.1004228 |
0.367 |
|
| 2014 |
Whiffin N, Hosking FJ, Farrington SM, Palles C, Dobbins SE, Zgaga L, Lloyd A, Kinnersley B, Gorman M, Tenesa A, Broderick P, Wang Y, Barclay E, Hayward C, Martin L, ... ... Gallinger S, et al. Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. Human Molecular Genetics. 23: 4729-37. PMID 24737748 DOI: 10.1093/Hmg/Ddu177 |
0.37 |
|
| 2014 |
Bharati R, Jenkins MA, Lindor NM, Le Marchand L, Gallinger S, Haile RW, Newcomb PA, Hopper JL, Win AK. Does risk of endometrial cancer for women without a germline mutation in a DNA mismatch repair gene depend on family history of endometrial cancer or colorectal cancer? Gynecologic Oncology. 133: 287-92. PMID 24631449 DOI: 10.1016/J.Ygyno.2014.03.011 |
0.416 |
|
| 2014 |
Lindor NM, Win AK, Gallinger S, Daftary D, Thibodeau SN, Silva R, Letra A. Colorectal cancer and self-reported tooth agenesis. Hereditary Cancer in Clinical Practice. 12: 7. PMID 24607150 DOI: 10.1186/1897-4287-12-7 |
0.408 |
|
| 2014 |
Cotterchio M, Lowcock E, Hudson TJ, Greenwood C, Gallinger S. Association between allergies and risk of pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 469-80. PMID 24554712 DOI: 10.1158/1055-9965.Epi-13-0965 |
0.34 |
|
| 2014 |
Downes MR, Allo G, McCluggage WG, Sy K, Ferguson SE, Aronson M, Pollett A, Gallinger S, Bilbily E, Shaw P, Clarke BA. Review of findings in prophylactic gynaecological specimens in Lynch syndrome with literature review and recommendations for grossing. Histopathology. 65: 228-39. PMID 24495259 DOI: 10.1111/His.12386 |
0.36 |
|
| 2014 |
Ahsan H, Halpern J, Kibriya MG, Pierce BL, Tong L, Gamazon E, McGuire V, Felberg A, Shi J, Jasmine F, Roy S, Brutus R, Argos M, Melkonian S, Chang-Claude J, ... ... Gallinger S, et al. A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 658-69. PMID 24493630 DOI: 10.1158/1055-9965.Epi-13-0340 |
0.355 |
|
| 2014 |
Win AK, Dowty JG, Cleary SP, Kim H, Buchanan DD, Young JP, Clendenning M, Rosty C, MacInnis RJ, Giles GG, Boussioutas A, Macrae FA, Parry S, Goldblatt J, Baron JA, ... ... Gallinger S, et al. Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology. 146: 1208-11.e1-5. PMID 24444654 DOI: 10.1053/J.Gastro.2014.01.022 |
0.359 |
|
| 2014 |
Bakry D, Aronson M, Durno C, Rimawi H, Farah R, Alharbi QK, Alharbi M, Shamvil A, Ben-Shachar S, Mistry M, Constantini S, Dvir R, Qaddoumi I, Gallinger S, Lerner-Ellis J, et al. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium. European Journal of Cancer (Oxford, England : 1990). 50: 987-96. PMID 24440087 DOI: 10.1016/J.Ejca.2013.12.005 |
0.326 |
|
| 2014 |
Kreso A, van Galen P, Pedley NM, Lima-Fernandes E, Frelin C, Davis T, Cao L, Baiazitov R, Du W, Sydorenko N, Moon YC, Gibson L, Wang Y, Leung C, Iscove NN, ... ... Gallinger S, et al. Self-renewal as a therapeutic target in human colorectal cancer. Nature Medicine. 20: 29-36. PMID 24292392 DOI: 10.1038/Nm.3418 |
0.324 |
|
| 2014 |
Peltekova VD, Lemire M, Qazi AM, Zaidi SH, Trinh QM, Bielecki R, Rogers M, Hodgson L, Wang M, D'Souza DJ, Zandi S, Chong T, Kwan JY, Kozak K, De Borja R, ... ... Gallinger S, et al. Identification of genes expressed by immune cells of the colon that are regulated by colorectal cancer-associated variants. International Journal of Cancer. Journal International Du Cancer. 134: 2330-41. PMID 24154973 DOI: 10.1002/Ijc.28557 |
0.722 |
|
| 2014 |
Cheng I, Kocarnik JM, Dumitrescu L, Lindor NM, Chang-Claude J, Avery CL, Caberto CP, Love SA, Slattery ML, Chan AT, Baron JA, Hindorff LA, Park SL, Schumacher FR, Hoffmeister M, ... ... Gallinger S, et al. Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia. Gut. 63: 800-7. PMID 23935004 DOI: 10.1136/Gutjnl-2013-305189 |
0.397 |
|
| 2014 |
Ananthakrishnan AN, Du M, Brenner H, Slattery ML, Berndt SI, Chang-Claude J, Fuchs C, Gallinger S, Giovannucci E, Harrison TA, Hoffmeister M, Hou L, Nan H, Newcomb PA, Potter JD, et al. Mo1906 Red Meat Is Associated With Risk of Colorectal Cancer, Independent of NAT2 Genetic Background: a Pooled Analysis of 13 Studies Gastroenterology. 146: S-688. DOI: 10.1016/S0016-5085(14)62496-3 |
0.365 |
|
| 2013 |
Wang H, Taverna D, Stram DO, Fortini BK, Cheng I, Wilkens LR, Burnett T, Makar KW, Lindor NM, Hopper JL, Gallinger S, Baron JA, Haile R, Kolonel LN, Henderson BE, et al. Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 2094-101. PMID 24045924 DOI: 10.1158/1055-9965.Epi-13-0694 |
0.351 |
|
| 2013 |
Makawita S, Dimitromanolakis A, Soosaipillai A, Soleas I, Chan A, Gallinger S, Haun RS, Blasutig IM, Diamandis EP. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9. Bmc Cancer. 13: 404. PMID 24007603 DOI: 10.1186/1471-2407-13-404 |
0.319 |
|
| 2013 |
Hiraki LT, Qu C, Hutter CM, Baron JA, Berndt SI, Bézieau S, Brenner H, Caan BJ, Casey G, Chang-Claude J, Chanock SJ, Conti DV, Duggan D, Fuchs CS, Gallinger S, et al. Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 2037-46. PMID 23983240 DOI: 10.1158/1055-9965.Epi-13-0209 |
0.315 |
|
| 2013 |
Bosetti C, Lucenteforte E, Bracci PM, Negri E, Neale RE, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, Zatonski W, et al. Ulcer, gastric surgery and pancreatic cancer risk: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 2903-10. PMID 23970016 DOI: 10.1093/Annonc/Mdt336 |
0.36 |
|
| 2013 |
Whiffin N, Dobbins SE, Hosking FJ, Palles C, Tenesa A, Wang Y, Farrington SM, Jones AM, Broderick P, Campbell H, Newcomb PA, Casey G, Conti DV, Schumacher F, Gallinger S, et al. Deciphering the genetic architecture of low-penetrance susceptibility to colorectal cancer. Human Molecular Genetics. 22: 5075-82. PMID 23904454 DOI: 10.1093/Hmg/Ddt357 |
0.424 |
|
| 2013 |
Phipps AI, Lindor NM, Jenkins MA, Baron JA, Win AK, Gallinger S, Gryfe R, Newcomb PA. Colon and rectal cancer survival by tumor location and microsatellite instability: the Colon Cancer Family Registry. Diseases of the Colon and Rectum. 56: 937-44. PMID 23838861 DOI: 10.1097/Dcr.0B013E31828F9A57 |
0.75 |
|
| 2013 |
Adams SV, Ahnen DJ, Baron JA, Campbell PT, Gallinger S, Grady WM, LeMarchand L, Lindor NM, Potter JD, Newcomb PA. Survival after inflammatory bowel disease-associated colorectal cancer in the Colon Cancer Family Registry. World Journal of Gastroenterology : Wjg. 19: 3241-8. PMID 23745025 DOI: 10.3748/Wjg.V19.I21.3241 |
0.321 |
|
| 2013 |
Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS. Liver resection for colorectal cancer metastases. Current Oncology (Toronto, Ont.). 20: e255-65. PMID 23737695 DOI: 10.3747/Co.20.1341 |
0.349 |
|
| 2013 |
DeRycke MS, Gunawardena SR, Middha S, Asmann YW, Schaid DJ, McDonnell SK, Riska SM, Eckloff BW, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Cicek MS, Jenkins MA, Duggan DJ, ... ... Gallinger SN, et al. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1239-51. PMID 23637064 DOI: 10.1158/1055-9965.Epi-12-1226 |
0.305 |
|
| 2013 |
Grant RC, Al-Sukhni W, Borgida AE, Holter S, Kanji ZS, McPherson T, Whelan E, Serra S, Trinh QM, Peltekova V, Stein LD, McPherson JD, Gallinger S. Exome sequencing identifies nonsegregating nonsense ATM and PALB2 variants in familial pancreatic cancer. Human Genomics. 7: 11. PMID 23561644 DOI: 10.1186/1479-7364-7-11 |
0.796 |
|
| 2013 |
Jiang X, Castelao JE, Vandenberg D, Carracedo A, Redondo CM, Conti DV, Paredes Cotoré JP, Potter JD, Newcomb PA, Passarelli MN, Jenkins MA, Hopper JL, Gallinger S, Le Marchand L, MartÃnez ME, et al. Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry. Plos One. 8: e60464. PMID 23560096 DOI: 10.1371/Journal.Pone.0060464 |
0.389 |
|
| 2013 |
Akbari MR, Anderson LN, Buchanan DD, Clendenning M, Jenkins MA, Win AK, Hopper JL, Giles GG, Nam R, Narod S, Gallinger S, Cleary SP. Germline HOXB13 p.Gly84Glu mutation and risk of colorectal cancer. Cancer Epidemiology. 37: 424-7. PMID 23541221 DOI: 10.1016/J.Canep.2013.03.003 |
0.422 |
|
| 2013 |
Devaud N, Gallinger S. Chemotherapy of MMR-deficient colorectal cancer. Familial Cancer. 12: 301-306. PMID 23539382 DOI: 10.1007/S10689-013-9633-Z |
0.508 |
|
| 2013 |
Win AK, Hopper JL, Buchanan DD, Young JP, Tenesa A, Dowty JG, Giles GG, Goldblatt J, Winship I, Boussioutas A, Young GP, Parry S, Baron JA, Duggan D, Gallinger S, et al. Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers? European Journal of Cancer (Oxford, England : 1990). 49: 1578-87. PMID 23434150 DOI: 10.1016/J.Ejca.2013.01.029 |
0.372 |
|
| 2013 |
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, Rosty C, Leggett B, Giles GG, Goldblatt J, Macrae FA, Parry S, Kalady MF, Baron JA, Ahnen DJ, ... ... Gallinger S, et al. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. Journal of the National Cancer Institute. 105: 274-9. PMID 23385444 DOI: 10.1093/Jnci/Djs525 |
0.43 |
|
| 2013 |
Win AK, Parry S, Parry B, Kalady MF, Macrae FA, Ahnen DJ, Young GP, Lipton L, Winship I, Boussioutas A, Young JP, Buchanan DD, Arnold J, Le Marchand L, Newcomb PA, ... ... Gallinger S, et al. Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Annals of Surgical Oncology. 20: 1829-36. PMID 23358792 DOI: 10.1245/S10434-012-2858-5 |
0.444 |
|
| 2013 |
Loo LW, Tiirikainen M, Cheng I, Lum-Jones A, Seifried A, Church JM, Gryfe R, Weisenberger DJ, Lindor NM, Gallinger S, Haile RW, Duggan DJ, Thibodeau SN, Casey G, Le Marchand L. Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. Genes, Chromosomes & Cancer. 52: 450-66. PMID 23341073 DOI: 10.1002/Gcc.22043 |
0.666 |
|
| 2013 |
Clendenning M, Walsh MD, Gelpi JB, Thibodeau SN, Lindor N, Potter JD, Newcomb P, LeMarchand L, Haile R, Gallinger S, Hopper JL, Jenkins MA, Rosty C, Young JP, et al. Detection of large scale 3' deletions in the PMS2 gene amongst Colon-CFR participants: have we been missing anything? Familial Cancer. 12: 563-6. PMID 23288611 DOI: 10.1007/S10689-012-9597-4 |
0.485 |
|
| 2013 |
Peters U, Jiao S, Schumacher FR, Hutter CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Casey G, Chan AT, ... ... Gallinger S, et al. Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology. 144: 799-807.e24. PMID 23266556 DOI: 10.1053/J.Gastro.2012.12.020 |
0.324 |
|
| 2013 |
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, Antill YC, Thibodeau SN, Casey G, Gallinger S, Marchand LL, Newcomb PA, Haile RW, Young GP, James PA, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Human Mutation. 34: 490-7. PMID 23255516 DOI: 10.1002/Humu.22262 |
0.449 |
|
| 2013 |
Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, Brown AM, Ng K, Ma J, Wienholds E, Dunant C, Pollett A, Gallinger S, McPherson J, Mullighan CG, Shibata D, et al. Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science (New York, N.Y.). 339: 543-8. PMID 23239622 DOI: 10.1126/science.1227670 |
0.327 |
|
| 2013 |
Rosty C, Walsh MD, Walters RJ, Clendenning M, Pearson SA, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, Goldblatt J, Tucker K, Greening S, et al. Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. The American Journal of Surgical Pathology. 37: 434-42. PMID 23211288 DOI: 10.1097/Pas.0B013E318270F748 |
0.438 |
|
| 2013 |
Walter T, Ho CS, Horgan AM, Warkentin A, Gallinger S, Greig PD, Kortan P, Knox JJ. Endoscopic or percutaneous biliary drainage for Klatskin tumors? Journal of Vascular and Interventional Radiology. 24: 113-121. PMID 23182938 DOI: 10.1016/J.Jvir.2012.09.019 |
0.303 |
|
| 2013 |
Wei AC, Sandhu L, Devitt KS, Gagliardi AR, Kennedy ED, Urbach DR, Gallinger S, Baxter NN. Practice patterns for the management of hepatic metastases from colorectal cancer: a mixed methods analysis. Annals of Surgical Oncology. 20: 1567-74. PMID 23124860 DOI: 10.1245/S10434-012-2698-3 |
0.391 |
|
| 2013 |
Nanji S, Cleary S, Ryan P, Guindi M, Selvarajah S, Al-Ali H, Grieg P, McGilvary I, Taylor B, Wei A, Moulton CA, Gallinger S. Up-front hepatic resection for metastatic colorectal cancer results in favorable long-term survival. Annals of Surgical Oncology. 20: 295-304. PMID 23054102 DOI: 10.1245/s10434-012-2424-1 |
0.314 |
|
| 2013 |
Clendenning M, Macrae FA, Walsh MD, Walters RJ, Thibodeau SN, Gunawardena SR, Potter JD, Haile RW, Gallinger S, Hopper JL, Jenkins MA, Rosty C, Young JP, Buchanan DD. Absence of PMS2 mutations in colon-CFR participants whose colorectal cancers demonstrate unexplained loss of MLH1 expression. Clinical Genetics. 83: 591-3. PMID 23017166 DOI: 10.1111/Cge.12011 |
0.451 |
|
| 2013 |
Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, Parsons MT, Michael D W, Gallinger S, Haile RW, Hopper JL, Jenkins MA, Lemarchand L, Lindor NM, Newcomb PA, et al. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Human Mutation. 34: 200-9. PMID 22949379 DOI: 10.1002/Humu.22213 |
0.347 |
|
| 2013 |
Skeldon SC, Semotiuk K, Aronson M, Holter S, Gallinger S, Pollett A, Kuk C, van Rhijn B, Bostrom P, Cohen Z, Fleshner NE, Jewett MA, Hanna S, Shariat SF, Van Der Kwast TH, et al. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. European Urology. 63: 379-85. PMID 22883484 DOI: 10.1016/J.Eururo.2012.07.047 |
0.422 |
|
| 2013 |
Kastrinos F, Steyerberg EW, Balmaña J, Mercado R, Gallinger S, Haile R, Casey G, Hopper JL, LeMarchand L, Lindor NM, Newcomb PA, Thibodeau SN, Syngal S. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut. 62: 272-9. PMID 22345660 DOI: 10.1136/Gutjnl-2011-301265 |
0.358 |
|
| 2012 |
Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL, Miller DK, Wilson PJ, Patch AM, Wu J, Chang DK, Cowley MJ, Gardiner BB, Song S, Harliwong I, ... ... Gallinger S, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 491: 399-405. PMID 23103869 DOI: 10.1038/Nature11547 |
0.316 |
|
| 2012 |
Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, et al. Identification of Lynch syndrome among patients with colorectal cancer. Jama. 308: 1555-65. PMID 23073952 DOI: 10.1001/Jama.2012.13088 |
0.325 |
|
| 2012 |
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, Parry S, Goldblatt J, Lipton L, Winship I, Leggett B, Tucker KM, Giles GG, Buchanan DD, Clendenning M, ... ... Gallinger S, et al. Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome. Journal of the National Cancer Institute. 104: 1363-72. PMID 22933731 DOI: 10.1093/Jnci/Djs351 |
0.444 |
|
| 2012 |
Plummer JM, Chin SN, Aronson M, Graham RP, Williams NP, Bapat B, Wharfe G, Pollett A, Gallinger S. Lynch syndrome in a predominantly Afrocentric population: a clinicopathological and genetic study. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 55: 294-300. PMID 22854115 DOI: 10.1503/Cjs.037410 |
0.339 |
|
| 2012 |
Duell EJ, Lucenteforte E, Olson SH, Bracci PM, Li D, Risch HA, Silverman DT, Ji BT, Gallinger S, Holly EA, Fontham EH, Maisonneuve P, Bueno-de-Mesquita HB, Ghadirian P, Kurtz RC, et al. Pancreatitis and pancreatic cancer risk: A pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4) Annals of Oncology. 23: 2964-2970. PMID 22767586 DOI: 10.1093/Annonc/Mds140 |
0.433 |
|
| 2012 |
Di Valentin T, Alam Y, Ali Alsharm A, Arif S, Aubin F, Biagi J, Booth CM, Bourque S, Burkes R, Champion P, Colwell B, Cripps C, Dallaire M, Dorreen M, Finn N, ... ... Gallinger S, et al. Eastern Canadian colorectal cancer consensus conference: application of new modalities of staging and treatment of gastrointestinal cancers. Current Oncology (Toronto, Ont.). 19: 169-74. PMID 22670096 DOI: 10.3747/Co.19.931 |
0.495 |
|
| 2012 |
Al-Sukhni W, Joe S, Lionel AC, Zwingerman N, Zogopoulos G, Marshall CR, Borgida A, Holter S, Gropper A, Moore S, Bondy M, Klein AP, Petersen GM, Rabe KG, Schwartz AG, ... ... Gallinger S, et al. Identification of germline genomic copy number variation in familial pancreatic cancer. Human Genetics. 131: 1481-94. PMID 22665139 DOI: 10.1007/S00439-012-1183-1 |
0.803 |
|
| 2012 |
Dunlop MG, Dobbins SE, Farrington SM, Jones AM, Palles C, Whiffin N, Tenesa A, Spain S, Broderick P, Ooi LY, Domingo E, Smillie C, Henrion M, Frampton M, Martin L, ... ... Gallinger S, et al. Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk. Nature Genetics. 44: 770-6. PMID 22634755 DOI: 10.1038/Ng.2293 |
0.31 |
|
| 2012 |
Brown CJ, Gallinger S, Church J. Long-term effects of aspirin on colorectal cancer. Journal of the American College of Surgeons. 214: 1023-6. PMID 22626547 DOI: 10.1016/j.jamcollsurg.2012.03.013 |
0.309 |
|
| 2012 |
Roberts NJ, Jiao Y, Yu J, Kopelovich L, Petersen GM, Bondy ML, Gallinger S, Schwartz AG, Syngal S, Cote ML, Axilbund J, Schulick R, Ali SZ, Eshleman JR, Velculescu VE, et al. ATM mutations in patients with hereditary pancreatic cancer Cancer Discovery. 2: 41-46. PMID 22585167 DOI: 10.1158/2159-8290.Cd-11-0194 |
0.417 |
|
| 2012 |
Sandhu L, Fox A, Nhan C, Barnett H, McLeod RS, Gallinger S, Moulton CA. Assessing the management of hepatic colorectal cancer metastases: is treatment consistent in Ontario? Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. 14: 409-13. PMID 22568418 DOI: 10.1111/j.1477-2574.2012.00467.x |
0.37 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, ... ... Gallinger S, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics. 44: 651-8. PMID 22561519 DOI: 10.1038/Ng.2270 |
0.353 |
|
| 2012 |
Win AK, Walters RJ, Buchanan DD, Jenkins MA, Sweet K, Frankel WL, de la Chapelle A, McKeone DM, Walsh MD, Clendenning M, Pearson SA, Pavluk E, Nagler B, Hopper JL, Gattas MR, ... ... Gallinger S, et al. Cancer risks for relatives of patients with serrated polyposis. The American Journal of Gastroenterology. 107: 770-8. PMID 22525305 DOI: 10.1038/Ajg.2012.52 |
0.493 |
|
| 2012 |
Li D, Duell EJ, Yu K, Risch HA, Olson SH, Kooperberg C, Wolpin BM, Jiao L, Dong X, Wheeler B, Arslan AA, Bueno-de-Mesquita HB, Fuchs CS, Gallinger S, Gross M, et al. Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer. Carcinogenesis. 33: 1384-90. PMID 22523087 DOI: 10.1093/Carcin/Bgs151 |
0.328 |
|
| 2012 |
Rosty C, Buchanan DD, Walsh MD, Pearson SA, Pavluk E, Walters RJ, Clendenning M, Spring KJ, Jenkins MA, Win AK, Hopper JL, Sweet K, Frankel WL, Aronson M, Gallinger S, et al. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. The American Journal of Surgical Pathology. 36: 876-82. PMID 22510757 DOI: 10.1097/Pas.0B013E31824E133F |
0.432 |
|
| 2012 |
Loo LW, Cheng I, Tiirikainen M, Lum-Jones A, Seifried A, Dunklee LM, Church JM, Gryfe R, Weisenberger DJ, Haile RW, Gallinger S, Duggan DJ, Thibodeau SN, Casey G, Le Marchand L. cis-Expression QTL analysis of established colorectal cancer risk variants in colon tumors and adjacent normal tissue. Plos One. 7: e30477. PMID 22363440 DOI: 10.1371/Journal.Pone.0030477 |
0.706 |
|
| 2012 |
Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship I, Macrae FA, Goldblatt J, Southey MC, Arnold J, Thibodeau SN, ... ... Gallinger S, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 958-64. PMID 22331944 DOI: 10.1200/Jco.2011.39.5590 |
0.368 |
|
| 2012 |
Schwenter F, Faughnan ME, Gradinger AB, Berk T, Gryfe R, Pollett A, Cohen Z, Gallinger S, Durno C. Juvenile polyposis, hereditary hemorrhagic telangiectasia, and early onset colorectal cancer in patients with SMAD4 mutation Journal of Gastroenterology. 47: 795-804. PMID 22331366 DOI: 10.1007/S00535-012-0545-8 |
0.706 |
|
| 2012 |
Durno CA, Aronson M, Tabori U, Malkin D, Gallinger S, Chan HS. Oncologic surveillance for subjects with biallelic mismatch repair gene mutations: 10 year follow-up of a kindred. Pediatric Blood & Cancer. 59: 652-6. PMID 22180144 DOI: 10.1002/Pbc.24019 |
0.446 |
|
| 2012 |
Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Semotiuk K, Grant R, Wilson S, Moore M, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: an eight-year experience. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 16: 771-83. PMID 22127781 DOI: 10.1007/S11605-011-1781-6 |
0.807 |
|
| 2012 |
Hart SL, Torbit LA, Crangle CJ, Esplen MJ, Holter S, Semotiuk K, Borgida A, Ardiles P, Rothenmund H, Gallinger S. Moderators of cancer-related distress and worry after a pancreatic cancer genetic counseling and screening intervention. Psycho-Oncology. 21: 1324-30. PMID 21774034 DOI: 10.1002/Pon.2026 |
0.494 |
|
| 2012 |
Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Human Genetics. 131: 217-34. PMID 21761138 DOI: 10.1007/S00439-011-1055-0 |
0.358 |
|
| 2012 |
Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, Holter S, Kwon J, Kalloger SE, Gilks CB, Gallinger S, Pollett A, Clarke BA. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries Cancer. 118: 681-688. PMID 21721000 DOI: 10.1002/Cncr.26323 |
0.353 |
|
| 2012 |
Schwenter F, Ratjen F, Berk T, Gallinger S, Gryfe R, Gradinger AB, Faughnan ME, Durno CA. Juvenile polyposis syndrome, SMAD4 mutations, and hereditary hemorrhagic telangiectasia. Journal of Pediatric Gastroenterology and Nutrition. 54: 120-2. PMID 21572342 DOI: 10.1097/Mpg.0B013E3182238514 |
0.327 |
|
| 2012 |
Lucenteforte E, La Vecchia C, Silverman D, Petersen GM, Bracci PM, Ji BT, Bosetti C, Li D, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, Baghurst PA, et al. Alcohol consumption and pancreatic cancer: A pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4) Annals of Oncology. 23: 374-382. PMID 21536662 DOI: 10.1093/Annonc/Mdr120 |
0.382 |
|
| 2012 |
Parry S, Win A, Parry B, Kalady M, Macrae F, Lindor N, Haile R, Newcomb P, Marchand LL, Gallinger S, Hopper J, Jenkins M. Metachronous colon cancer risk following surgery for first primary rectal cancer in Lynch syndrome Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S2-A74 |
0.51 |
|
| 2012 |
Dowty J, Win A, Buchanan D, Macinnis R, Lindor N, Thibodeau S, Casey G, Gallinger S, LeMarchand L, Newcomb P, Haile R, Goldblatt J, Parry S, Macrae F, Hopper J, et al. Substantial unexplained variation in cancer risks for MLH1 and MSH2 mutation carriers Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S2-A33 |
0.477 |
|
| 2012 |
Begley KN, Mukhopadhyay D, Petersen GM, Protopopov A, Thayer S, Chin L, Ibrahimov E, Shaw P, Hudson T, Gallinger S, Tsao M, Stein L, McPherson JD, Muthuswamy L, Beck T, et al. Abstract A9: The pancreatic ductal adenocarcinoma project at the Ontario Institute for Cancer Research. Cancer Research. 72. DOI: 10.1158/1538-7445.Panca2012-A9 |
0.373 |
|
| 2012 |
Peltekova V, Lemire M, Trinh Q, Qazi A, Bielecki R, Hodgson-Jensen L, D'Souza D, Zandi S, Chong T, De Borja R, Timms L, Rangrej J, Volar M, Chan-Seng-Yue M, Beck T, ... ... Gallinger S, et al. 104 Tumor Microenvironment and Genetic Association With Colorectal Cancer Risk European Journal of Cancer. 48: S25. DOI: 10.1016/S0959-8049(12)70808-0 |
0.47 |
|
| 2011 |
Al-Sukhni W, Borgida A, Rothenmund H, Holter S, Wilson S, Moore MJ, Narod S, Jhaveri K, Haider MA, Gallinger S. Screening for pancreatic cancer in a high-risk cohort: A 7-year experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4045. PMID 28020520 DOI: 10.1200/Jco.2011.29.15_Suppl.4045 |
0.512 |
|
| 2011 |
Sinicrope F, Benatti P, Foster NR, Marsoni S, Monges G, Labianca R, Yothers GA, Gallinger S, Sargent DJ. Detecting deficient DNA mismatch repair in stage II and III colon cancers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 419. PMID 27985801 DOI: 10.1200/Jco.2011.29.4_Suppl.419 |
0.396 |
|
| 2011 |
Sinicrope FA, Foster NR, Thibodeau SN, Marsoni S, Monges G, Labianca R, Yothers G, Allegra C, Moore MJ, Gallinger S, Sargent DJ. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy Journal of the National Cancer Institute. 103: 863-875. PMID 21597022 DOI: 10.1093/jnci/djr153 |
0.311 |
|
| 2011 |
Rawson JB, Mrkonjic M, Daftary D, Dicks E, Buchanan DD, Younghusband HB, Parfrey PS, Young JP, Pollett A, Green RC, Gallinger S, McLaughlin JR, Knight JA, Bapat B. Promoter methylation of Wnt5a is associated with microsatellite instability and BRAF V600E mutation in two large populations of colorectal cancer patients. British Journal of Cancer. 104: 1906-12. PMID 21587258 DOI: 10.1038/Bjc.2011.165 |
0.346 |
|
| 2011 |
Win AK, Dowty JG, English DR, Campbell PT, Young JP, Winship I, Macrae FA, Lipton L, Parry S, Young GP, Buchanan DD, MartÃnez ME, Jacobs ET, Ahnen DJ, Haile RW, ... ... Gallinger S, et al. Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. British Journal of Cancer. 105: 162-9. PMID 21559014 DOI: 10.1038/Bjc.2011.172 |
0.323 |
|
| 2011 |
Cicek MS, Lindor NM, Gallinger S, Bapat B, Hopper JL, Jenkins MA, Young J, Buchanan D, Walsh MD, Le Marchand L, Burnett T, Newcomb PA, Grady WM, Haile RW, Casey G, et al. Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. The Journal of Molecular Diagnostics : Jmd. 13: 271-81. PMID 21497289 DOI: 10.1016/J.Jmoldx.2010.12.004 |
0.35 |
|
| 2011 |
Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L, Parry S, Thibodeau SN, Haile RW, Gallinger S, Le Marchand L, et al. Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstetrics and Gynecology. 117: 899-905. PMID 21422863 DOI: 10.1097/Aog.0B013E3182110Ea3 |
0.365 |
|
| 2011 |
Parry S, Win AK, Macrae FA, Parry B, Gurrin LC, Lindor NM, Gallinger S, Hopper JL, Jenkins MA. 14th Annual Meeting of the Collaborative Group of the Americas on Inherited Colorectal Cancer Dallas, TX, USA. 12-13 October 2010. Abstracts. Hereditary Cancer in Clinical Practice. 9: O1. PMID 21406122 DOI: 10.1186/1897-4287-9-S1-O1 |
0.314 |
|
| 2011 |
Rawson JB, Manno M, Mrkonjic M, Daftary D, Dicks E, Buchanan DD, Younghusband HB, Parfrey PS, Young JP, Pollett A, Green RC, Gallinger S, McLaughlin JR, Knight JA, Bapat B. Promoter methylation of Wnt antagonists DKK1 and SFRP1 is associated with opposing tumor subtypes in two large populations of colorectal cancer patients. Carcinogenesis. 32: 741-7. PMID 21304055 DOI: 10.1093/Carcin/Bgr020 |
0.303 |
|
| 2011 |
Borgida AE, Ashamalla S, Al-Sukhni W, Rothenmund H, Urbach D, Moore M, Michelle Cotterchio, Gallinger S. Management of pancreatic adenocarcinoma in Ontario, Canada: A population-based study using novel case ascertainment Canadian Journal of Surgery. 54: 54-60. PMID 21251433 DOI: 10.1503/Cjs.026409 |
0.764 |
|
| 2011 |
Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, et al. Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 22: 1420-6. PMID 21245160 DOI: 10.1093/Annonc/Mdq613 |
0.395 |
|
| 2011 |
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, Baron JA, Giles GG, Leggett BA, Winship I, Lipton L, Young GP, Young JP, Lodge CJ, Southey MC, ... ... Gallinger S, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 60: 950-7. PMID 21193451 DOI: 10.1136/Gut.2010.228056 |
0.428 |
|
| 2011 |
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC, Le Marchand L, Newcomb PA, Haile RW, Lindor NM, Hopper JL, ... Gallinger S, et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 129: 2256-62. PMID 21171015 DOI: 10.1002/Ijc.25870 |
0.397 |
|
| 2011 |
Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Wong N, Chong G, Narod SA, Levine DA, Bogomolniy F, Aronson M, Thibodeau SN, Hunt KS, Rennert G, Gallinger S, Gruber SB, et al. Characterization of two Ashkenazi Jewish founder mutations in MSH6 gene causing Lynch syndrome. Clinical Genetics. 79: 512-22. PMID 21155762 DOI: 10.1111/J.1399-0004.2010.01594.X |
0.315 |
|
| 2011 |
Limburg PJ, Harmsen WS, Chen HH, Gallinger S, Haile RW, Baron JA, Casey G, Woods MO, Thibodeau SN, Lindor NM. Prevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 9: 497-502. PMID 21056691 DOI: 10.1016/J.Cgh.2010.10.021 |
0.333 |
|
| 2011 |
Kastrinos F, Steyerberg EW, Mercado R, Balmaña J, Holter S, Gallinger S, Siegmund KD, Church JM, Jenkins MA, Lindor NM, Thibodeau SN, Burbidge LA, Wenstrup RJ, Syngal S. The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology. 140: 73-81. PMID 20727894 DOI: 10.1053/J.Gastro.2010.08.021 |
0.345 |
|
| 2011 |
Loo LWM, Cheng I, Tiirikainen M, Lum-Jones A, Seifried A, Dunklee LM, Gallinger S, Thibodeau SN, Casey G, Marchand LL. Abstract 4732: Cis-expression QTL analysis of established risk variants for colorectal cancer Cancer Research. 71: 4732-4732. DOI: 10.1158/1538-7445.Am2011-4732 |
0.476 |
|
| 2011 |
Bertuccio P, La Vecchia C, Silverman DT, Petersen GM, Bracci PM, Negri E, Li D, Risch HA, Olson SH, Gallinger S, Miller AB, Bueno-de-Mesquita HB, Talamini R, Polesel J, Ghadirian P, et al. Reply to are cohort data on smokeless tobacco use and pancreatic cancer confounded by alcohol use? Annals of Oncology. 22: 1931-1932. DOI: 10.1093/Annonc/Mdr305 |
0.335 |
|
| 2010 |
Theodoratou E, Campbell H, Tenesa A, Houlston R, Webb E, Lubbe S, Broderick P, Gallinger S, Croitoru EM, Jenkins MA, Win AK, Cleary SP, Koessler T, Pharoah PD, Küry S, et al. A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. British Journal of Cancer. 103: 1875-84. PMID 21063410 DOI: 10.1038/sj.bjc.6605966 |
0.335 |
|
| 2010 |
Woods MO, Younghusband HB, Parfrey PS, Gallinger S, McLaughlin J, Dicks E, Stuckless S, Pollett A, Bapat B, Mrkonjic M, de la Chapelle A, Clendenning M, Thibodeau SN, Simms M, Dohey A, et al. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut. 59: 1369-77. PMID 20682701 DOI: 10.1136/Gut.2010.208462 |
0.504 |
|
| 2010 |
Buchanan DD, Sweet K, Drini M, Jenkins MA, Win AK, English DR, Walsh MD, Clendenning M, McKeone DM, Walters RJ, Roberts A, Pearson SA, Pavluk E, Hopper JL, Gattas MR, ... ... Gallinger S, et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. Plos One. 5: e11636. PMID 20661287 DOI: 10.1371/Journal.Pone.0011636 |
0.321 |
|
| 2010 |
Maheu C, Vodermaier A, Rothenmund H, Gallinger S, Ardiles P, Semotiuk K, Holter S, Thayalan S, Esplen MJ. Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. Familial Cancer. 9: 617-24. PMID 20623197 DOI: 10.1007/S10689-010-9354-5 |
0.466 |
|
| 2010 |
Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1831-9. PMID 20570909 DOI: 10.1158/1055-9965.Epi-10-0055 |
0.465 |
|
| 2010 |
Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, ... ... Gallinger S, et al. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Research. 70: 5409-18. PMID 20551049 DOI: 10.1158/0008-5472.Can-10-0188 |
0.434 |
|
| 2010 |
Durno CA, Holter S, Sherman PM, Gallinger S. The gastrointestinal phenotype of germline biallelic mismatch repair gene mutations. The American Journal of Gastroenterology. 105: 2449-56. PMID 20531397 DOI: 10.1038/Ajg.2010.215 |
0.4 |
|
| 2010 |
Sargent DJ, Marsoni S, Monges G, Thibodeau SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri V, Ribic C, Grothey A, Moore M, Zaniboni A, Seitz JF, ... ... Gallinger S, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil-based adjuvant therapy in colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 3219-26. PMID 20498393 DOI: 10.1200/JCO.2009.27.1825 |
0.317 |
|
| 2010 |
Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I, Gerhard DS, Guttmacher A, Guyer M, Hemsley FM, Jennings JL, ... ... Gallinger S, et al. International network of cancer genome projects. Nature. 464: 993-8. PMID 20393554 DOI: 10.1038/Nature08987 |
0.434 |
|
| 2010 |
Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, Potter JD, Baron JA, Frazier ML, Amos CI. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1331-9. PMID 20145170 DOI: 10.1158/1078-0432.Ccr-09-1877 |
0.398 |
|
| 2010 |
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, Vriends AH, Cartwright NR, Barnetson RA, Farrington SM, Tenesa A, Hampel H, Buchanan D, Arnold S, ... ... Gallinger S, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. Journal of the National Cancer Institute. 102: 193-201. PMID 20028993 DOI: 10.1093/Jnci/Djp473 |
0.486 |
|
| 2010 |
Tomlinson IP, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäki I, Niittymäkix I, Tuupanen S, Tuupanenx S, Aaltonen LA, Hemminki K, Lindblom A, et al. COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. British Journal of Cancer. 102: 447-54. PMID 19920828 DOI: 10.1038/Sj.Bjc.6605338 |
0.504 |
|
| 2010 |
Perera S, Ramyar L, Mitri A, Pollett A, Gallinger S, Speevak MD, Aronson M, Bapat B. A novel complex mutation in MSH2 contributes to both Muir-Torre and Lynch Syndrome. Journal of Human Genetics. 55: 37-41. PMID 19911012 DOI: 10.1038/Jhg.2009.119 |
0.343 |
|
| 2010 |
Lindor NM, Yang P, Evans I, Schowalter K, De Andrade M, Li J, Jeavons E, Peterson G, Gallinger S, Bapat B, Hopper J, Jass J, Jenkins M, Templeton A, Potter J, et al. Alpha-1-antitrypsin deficiency and smoking as risk factors for mismatch repair deficient colorectal cancer: a study from the colon cancer family registry. Molecular Genetics and Metabolism. 99: 157-9. PMID 19853488 DOI: 10.1016/J.Ymgme.2009.09.010 |
0.463 |
|
| 2010 |
Sinicrope F, Foster NR, Sargent DJ, Gallinger S, Benatti P, Marsoni S, Monges G, Labianca R, O'Connell MJ, Allegra CJ. DNA mismatch repair status and site of tumor recurrence in stage II and III colon cancers treated in 5-fluorouracil-based adjuvant therapy trials. Journal of Clinical Oncology. 28: 3519-3519. DOI: 10.1200/Jco.2010.28.15_Suppl.3519 |
0.398 |
|
| 2010 |
Kim GP, Marsoni S, Monges G, Allegra CJ, Thibodeau SN, Hamilton SR, Kabat B, Yothers GA, Gallinger S, Sargent DJ. Analysis of time-dependent patterns of treatment effect and failure to explain the predictive role of deficient mismatch repair (dMMR) in stage II and III colon cancer (CC). Journal of Clinical Oncology. 28: 3518-3518. DOI: 10.1200/Jco.2010.28.15_Suppl.3518 |
0.31 |
|
| 2010 |
Parry S, Win A, Macrae F, Parry B, Lindor NM, Gallinger S, Hopper JL, Jenkins MA. Metachronous colorectal cancer in mismatch repair gene mutation carriers: The advantage of more extensive surgery. Journal of Clinical Oncology. 28: 3515-3515. DOI: 10.1200/Jco.2010.28.15_Suppl.3515 |
0.509 |
|
| 2010 |
Raskin L, Schwenter F, Freytsis M, Tischkowitz M, Levine DA, Narod S, Gallinger S, Rennert G, Foulkes W, Gruber SB. Characterization of new Ashkenazi Jewish founder mutations in MSH6 causing Lynch syndrome. Journal of Clinical Oncology. 28: 1514-1514. DOI: 10.1200/Jco.2010.28.15_Suppl.1514 |
0.414 |
|
| 2010 |
Antill YC, Dowty J, Win A, Thompson T, Lindor NM, Gallinger S, Winship I, Jenkins MA. Association of Lynch syndrome and risk of invasive cervical cancer. Journal of Clinical Oncology. 28: 1501-1501. DOI: 10.1200/Jco.2010.28.15_Suppl.1501 |
0.539 |
|
| 2010 |
Aronson M, Gallinger S, Rothenmund H, Semotiuk K, Holter S, Berk T, Pollett A, Cohen Z, Bapat B, Kim H, Gryfe R. Clinicopathologic and genetic features of young patients with colorectal cancer Hereditary Cancer in Clinical Practice. 8: P2. DOI: 10.1186/1897-4287-8-S1-P2 |
0.732 |
|
| 2010 |
Bapat B, Rawson JB, Mrkonjic M, Green RC, Gallinger S, Younghusband B, McLaughlin J, Knight JA. Abstract B28: Epigenetic contribution of Wnt antagonists SFRP1 and DKK1 as prognostic markers in colorectal cancer Clinical Cancer Research. 16. DOI: 10.1158/1078-0432.Tcme10-B28 |
0.418 |
|
| 2010 |
Tomlinson IPM, Dunlop M, Campbell H, Zanke B, Gallinger S, Hudson T, Koessler T, Pharoah PD, Niittymäki I, Tuupanen S, Aaltonen LA, Hemminki K, Lindblom A, Försti A, Sieber O, et al. Erratum: COGENT (COlorectal cancer GENeTics): An international consortium to study the role of polymorphic variation on the risk of colorectal cancer (British Journal of Cancer 102 (447-454) DOI: 10.1038/sj.bjc.6605338)) British Journal of Cancer. 102. DOI: 10.1038/Sj.Bjc.6605518 |
0.413 |
|
| 2010 |
Guindi M, Ryan P, Nanji S, Pollett A, Moore M, Moulton C-, Gallinger S. 216 Oxaliplatin-Associated Vascular Liver Injury In Metastatic Colorectal Cancer: Pathologic Examination Limited To Sinusoidal Dilation Misses The Majority Of Parenchymal Injuries Journal of Hepatology. 52. DOI: 10.1016/S0168-8278(10)60218-8 |
0.33 |
|
| 2009 |
Mackay H, Gallinger S, Tsao M, McLachlin CM, Kieser K, Eisenhauer E, Tu D, Oza A. Microsatellite instability and loss of PTEN expression in early versus late-stage endometrial cancer: Results from studies of the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5534. PMID 27962490 DOI: 10.1200/jco.2009.27.15_suppl.5534 |
0.36 |
|
| 2009 |
Gallinger S. Hereditary colorectal cancer. Preface. Surgical Oncology Clinics of North America. 18: xiii-xiv. PMID 19793565 DOI: 10.1016/j.soc.2009.09.001 |
0.417 |
|
| 2009 |
Choi YH, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, Gallinger S, McLaughlin J, Aronson M, Briollais L. Penetrance of colorectal cancer among MLH1/MSH2 carriers participating in the colorectal cancer familial registry in Ontario. Hereditary Cancer in Clinical Practice. 7: 14. PMID 19698169 DOI: 10.1186/1897-4287-7-14 |
0.455 |
|
| 2009 |
Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, Fuchs CS, Petersen GM, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Zheng W, Albanes D, Bamlet W, Berg CD, ... ... Gallinger S, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nature Genetics. 41: 986-90. PMID 19648918 DOI: 10.1038/Ng.429 |
0.336 |
|
| 2009 |
Jang JH, Cotterchio M, Gallinger S, Knight JA, Daftary D. Family history of hormonal cancers and colorectal cancer risk: a case-control study conducted in Ontario. International Journal of Cancer. 125: 918-25. PMID 19437533 DOI: 10.1002/ijc.24385 |
0.381 |
|
| 2009 |
Wirtzfeld DA, Mikula L, Gryfe R, Ravani P, Dicks EL, Parfrey P, Gallinger S, Pollett WG. Concordance with clinical practice guidelines for adjuvant chemotherapy in patients with stage I-III colon cancer: experience in 2 Canadian provinces. Canadian Journal of Surgery. Journal Canadien De Chirurgie. 52: 92-7. PMID 19399202 |
0.72 |
|
| 2009 |
Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, et al. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 967-75. PMID 19258475 DOI: 10.1158/1055-9965.Epi-08-0878 |
0.506 |
|
| 2009 |
Cleary SP, Cotterchio M, Jenkins MA, Kim H, Bristow R, Green R, Haile R, Hopper JL, LeMarchand L, Lindor N, Parfrey P, Potter J, Younghusband B, Gallinger S. Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology. 136: 1251-60. PMID 19245865 DOI: 10.1053/J.Gastro.2008.12.050 |
0.393 |
|
| 2009 |
Anderson LN, Cotterchio M, Gallinger S. Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada. Cancer Causes & Control : Ccc. 20: 825-34. PMID 19194662 DOI: 10.1007/s10552-009-9303-5 |
0.336 |
|
| 2009 |
Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey AB, Harper PA. Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3098-107. PMID 18990750 DOI: 10.1158/1055-9965.EPI-08-0341 |
0.383 |
|
| 2009 |
Esplen MJ, Stuckless N, Berk T, Butler K, Gallinger S. The FAP self-concept scale (adult form). Familial Cancer. 8: 39-50. PMID 18704759 DOI: 10.1007/S10689-008-9204-X |
0.382 |
|
| 2009 |
Kim G, Marsoni S, Monges G, Thibodeau S, Labianca R, Hamilton S, Kabat B, Sinicrope F, Gallinger S, Sargent D. 6009 Time-dependent patterns of treatment effect and failure as an explanation for the predictive role of deficient mismatch repair (dMMR) in stage II and III colon cancer Ejc Supplements. 7: 323-324. DOI: 10.1016/S1359-6349(09)71104-8 |
0.337 |
|
| 2008 |
Al-Sukhni W, Rothenmund H, Borgida AE, Zogopoulos G, O’Shea A, Pollett A, Gallinger S. Germline BRCA1 mutations predispose to pancreatic adenocarcinoma Human Genetics. 124: 271-278. PMID 18762988 DOI: 10.1007/S00439-008-0554-0 |
0.813 |
|
| 2008 |
Zogopoulos G, Jorgensen C, Bacani J, Montpetit A, Lepage P, Ferretti V, Chad L, Selvarajah S, Zanke B, Hudson TJ, Pawson T, Gallinger S. Germline EPHB2 receptor variants in familial colorectal cancer. Plos One. 3: e2885. PMID 18682749 DOI: 10.1371/Journal.Pone.0002885 |
0.441 |
|
| 2008 |
Al-Sukhni W, Aronson M, Gallinger S. Hereditary Colorectal Cancer Syndromes: Familial Adenomatous Polyposis and Lynch Syndrome Surgical Clinics of North America. 88: 819-844. PMID 18672142 DOI: 10.1016/J.Suc.2008.04.012 |
0.814 |
|
| 2008 |
Cleary SP, Kim H, Croitoru ME, Redston M, Knight JA, Gallinger S, Gryfe R. Missense Polymorphisms in the Adenomatous Polyposis Coli Gene and Colorectal Cancer Risk Diseases of the Colon & Rectum. 51: 1467-1474. PMID 18612690 DOI: 10.1007/S10350-008-9356-7 |
0.752 |
|
| 2008 |
O’Shea AM, Cleary SP, Croitoru MA, Kim H, Berk T, Monga N, Riddell RH, Pollett A, Gallinger S. Pathological features of colorectal carcinomas in MYH-associated polyposis. Histopathology. 53: 184-194. PMID 18564191 DOI: 10.1111/J.1365-2559.2008.03071.X |
0.491 |
|
| 2008 |
Govindarajan A, Fraser N, Cranford V, Wirtzfeld D, Gallinger S, Law CH, Smith AJ, Gagliardi AR. Predictors of multivisceral resection in patients with locally advanced colorectal cancer. Annals of Surgical Oncology. 15: 1923-30. PMID 18473145 DOI: 10.1245/S10434-008-9930-1 |
0.464 |
|
| 2008 |
Jackson CC, Holter S, Pollett A, Clendenning M, Chou S, Senter L, Ramphal R, Gallinger S, Boycott K. Café-au-lait macules and pediatric malignancy caused by biallelic mutations in the DNA mismatch repair (MMR) gene PMS2. Pediatric Blood & Cancer. 50: 1268-70. PMID 18273873 DOI: 10.1002/Pbc.21514 |
0.385 |
|
| 2008 |
Lo DS, Pollett A, Siu LL, Gallinger S, Burkes RL. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer. Cancer. 112: 50-54. PMID 18008365 DOI: 10.1002/Cncr.23136 |
0.43 |
|
| 2008 |
Al-Sukhni W, Gallinger S, Pratzer A, Wei A, Ho CS, Kortan P, Taylor BR, Grant DR, McGilvray I, Cattral MS, Langer B, Greig PD. Recurrent pyogenic cholangitis with hepatolithiasis--the role of surgical therapy in North America. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 12: 496-503. PMID 17999121 DOI: 10.1007/S11605-007-0398-2 |
0.743 |
|
| 2008 |
Sargent DJ, Marsoni S, Thibodeau SN, Labianca R, Hamilton SR, Torri V, Monges G, Ribic C, Grothey A, Gallinger S. Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials Journal of Clinical Oncology. 26: 4008-4008. DOI: 10.1200/Jco.2008.26.15_Suppl.4008 |
0.321 |
|
| 2007 |
Poynter JN, Figueiredo JC, Conti DV, Kennedy K, Gallinger S, Siegmund KD, Casey G, Thibodeau SN, Jenkins MA, Hopper JL, Byrnes GB, Baron JA, Goode EL, Tiirikainen M, Lindor N, et al. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Research. 67: 11128-32. PMID 18056436 DOI: 10.1158/0008-5472.Can-07-3239 |
0.316 |
|
| 2007 |
Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2331-43. PMID 17982118 DOI: 10.1158/1055-9965.Epi-07-0648 |
0.486 |
|
| 2007 |
Mrkonjic M, Raptis S, Green RC, Monga N, Daftary D, Dicks E, Younghusband HB, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer. Carcinogenesis. 28: 2575-80. PMID 17942459 DOI: 10.1093/Carcin/Bgm229 |
0.322 |
|
| 2007 |
Esplen MJ, Madlensky L, Aronson M, Rothenmund H, Gallinger S, Butler K, Toner B, Wong J, Manno M, McLaughlin J. Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: Motivational factors and psychosocial functioning Clinical Genetics. 72: 394-401. PMID 17892499 DOI: 10.1111/J.1399-0004.2007.00893.X |
0.5 |
|
| 2007 |
Campbell PT, Cotterchio M, Dicks E, Parfrey P, Gallinger S, McLaughlin JR. Excess Body Weight and Colorectal Cancer Risk in Canada: Associations in Subgroups of Clinically Defined Familial Risk of Cancer Cancer Epidemiology, Biomarkers & Prevention. 16: 1735-1744. PMID 17855691 DOI: 10.1158/1055-9965.Epi-06-1059 |
0.353 |
|
| 2007 |
Madlensky L, Daftary D, Burnett T, Harmon P, Jenkins M, Maskiell J, Nigon S, Phillips K, Templeton A, Limburg PJ, Haile RW, Potter JD, Gallinger S, Baron JA. Accuracy of colorectal polyp self-reports: findings from the colon cancer family registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1898-901. PMID 17726139 DOI: 10.1158/1055-9965.Epi-07-0151 |
0.322 |
|
| 2007 |
Boardman LA, Morlan BW, Rabe KG, Petersen GM, Lindor NM, Nigon SK, Goldberg J, Gallinger S. {A figure is presented}Colorectal Cancer Risks in Relatives of Young-Onset Cases: Is Risk the Same Across All First-Degree Relatives? Clinical Gastroenterology and Hepatology. 5: 1195-1198. PMID 17702662 DOI: 10.1016/j.cgh.2007.06.001 |
0.43 |
|
| 2007 |
Cleary SP, Dawson LA, Knox JJ, Gallinger S. Cancer of the gallbladder and extrahepatic bile ducts. Current Problems in Surgery. 44: 396-482. PMID 17693325 DOI: 10.1067/j.cpsurg.2007.04.006 |
0.372 |
|
| 2007 |
Jenkins MA, Hayashi S, O'Shea AM, Burgart LJ, Smyrk TC, Shimizu D, Waring PM, Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles GG, ... ... Gallinger S, et al. Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study. Gastroenterology. 133: 48-56. PMID 17631130 DOI: 10.1053/J.Gastro.2007.04.044 |
0.36 |
|
| 2007 |
Kohut K, Manno M, Gallinger S, Esplen MJ. Should healthcare providers have a duty to warn family members of individuals with an HNPCC-causing mutation? A survey of patients from the Ontario Familial Colon Cancer Registry. Journal of Medical Genetics. 44: 404-7. PMID 17551085 DOI: 10.1136/jmg.2006.047357 |
0.411 |
|
| 2007 |
Campbell PT, Newcomb P, Gallinger S, Cotterchio M, McLaughlin JI. Exogenous hormones and colorectal cancer risk in Canada: associations stratified by clinically defined familial risk of cancer Cancer Causes & Control. 18: 723-733. PMID 17549595 DOI: 10.1007/S10552-007-9015-7 |
0.373 |
|
| 2007 |
Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N, Suriano G, Zaor S, Van Manen L, Gilpin C, Nikkel S, Connolly-Wilson M, Weissman S, Rubinstein WS, Sebold C, ... ... Gallinger S, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. Jama. 297: 2360-72. PMID 17545690 DOI: 10.1001/Jama.297.21.2360 |
0.355 |
|
| 2007 |
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S, Au HJ, Murawa P, Walde D, Wolff RA, Campos D, Lim R, Ding K, Clark G, Voskoglou-Nomikos T, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 1960-6. PMID 17452677 DOI: 10.1200/JCO.2006.07.9525 |
0.335 |
|
| 2007 |
Zogopoulos G, Rothenmund H, Eppel A, Ash C, Akbari MR, Hedley D, Narod SA, Gallinger S. The P239S palladin variant does not account for a significant fraction of hereditary or early onset pancreas cancer. Human Genetics. 121: 635-7. PMID 17415588 DOI: 10.1007/S00439-007-0361-Z |
0.383 |
|
| 2007 |
Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. Journal of the National Cancer Institute. 99: 463-74. PMID 17374836 DOI: 10.1093/Jnci/Djk095 |
0.378 |
|
| 2007 |
Klein AP, De Andrade M, Hruban RH, Bondy M, Schwartz AG, Gallinger S, Lynch HT, Syngal S, Rabe KG, Goggins MG, Petersen GM. Linkage analysis of chromosome 4 in families with familial pancreatic cancer Cancer Biology and Therapy. 6: 320-323. PMID 17312386 DOI: 10.4161/Cbt.6.3.3721 |
0.34 |
|
| 2007 |
Couch FJ, Johnson MR, Rabe KG, Brune K, de Andrade M, Goggins M, Rothenmund H, Gallinger S, Klein A, Petersen GM, Hruban RH. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 342-6. PMID 17301269 DOI: 10.1158/1055-9965.EPI-06-0783 |
0.381 |
|
| 2007 |
Croitoru ME, Cleary SP, Berk T, Di Nicola N, Kopolovic I, Bapat B, Gallinger S. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients. Journal of Surgical Oncology. 95: 499-506. PMID 17219385 DOI: 10.1002/Jso.20724 |
0.308 |
|
| 2007 |
Labbé E, Lock L, Letamendia A, Gorska AE, Gryfe R, Gallinger S, Moses HL, Attisano L. Transcriptional cooperation between the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Research. 67: 75-84. PMID 17210685 DOI: 10.1158/0008-5472.Can-06-2559 |
0.627 |
|
| 2007 |
Cotterchio M, Boucher BA, Manno M, Gallinger S, Okey A, Harper P. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk. The Journal of Nutrition. 136: 3046-53. PMID 17116718 DOI: 10.1093/jn/136.12.3046 |
0.349 |
|
| 2007 |
Sahajpal A, Vollmer CM, Dixon E, Chan EK, Wei A, Cattral MS, Taylor BR, Grant DR, Greig PD, Gallinger S. Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. Journal of Surgical Oncology. 95: 22-7. PMID 17066435 DOI: 10.1002/jso.20632 |
0.354 |
|
| 2007 |
Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Familial Cancer. 6: 53-62. PMID 17039269 DOI: 10.1007/S10689-006-9104-X |
0.465 |
|
| 2007 |
Durno CA, Gallinger S. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle. Journal of Pediatric Gastroenterology and Nutrition. 43: 5-15. PMID 16819371 DOI: 10.1097/01.mpg.0000221889.36501.bb |
0.431 |
|
| 2006 |
Chen S, Wang W, Lee S, Nafa K, Lee J, Romans K, Watson P, Gruber SB, Euhus D, Kinzler KW, Jass J, Gallinger S, Lindor NM, Casey G, Ellis N, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. Jama. 296: 1479-87. PMID 17003396 DOI: 10.1001/Jama.296.12.1479 |
0.407 |
|
| 2006 |
Bacani JT, Soares M, Zwingerman R, Nicola Nd, Senz J, Riddell R, Huntsman DG, Gallinger S. CDH1/E-cadherin germline mutations in early-onset gastric cancer Journal of Medical Genetics. 43: 867-872. PMID 16801346 DOI: 10.1136/Jmg.2006.043133 |
0.479 |
|
| 2006 |
Petersen GM, Andrade MD, Goggins M, Hruban RH, Bondy M, Korczak JF, Gallinger S, Lynch HT, Syngal S, Rabe KG, Seminara D, Klein AP. Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiology, Biomarkers & Prevention. 15: 704-710. PMID 16614112 DOI: 10.1158/1055-9965.Epi-05-0734 |
0.363 |
|
| 2006 |
Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Annals of Surgical Oncology. 13: 668-76. PMID 16523369 DOI: 10.1245/ASO.2006.05.039 |
0.343 |
|
| 2006 |
Shah SA, Haddad R, Al-Sukhni W, Kim RD, Greig PD, Grant DR, Taylor BR, Langer B, Gallinger S, Wei AC. Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. Journal of the American College of Surgeons. 202: 468-75. PMID 16500252 DOI: 10.1016/j.jamcollsurg.2005.11.008 |
0.788 |
|
| 2006 |
Jenkins MA, Croitoru ME, Monga N, Cleary SP, Cotterchio M, Hopper JL, Gallinger S. Risk of colorectal cancer in monoallelic and biallelic carriers of MYH mutations: a population-based case-family study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 312-4. PMID 16492921 DOI: 10.1158/1055-9965.EPI-05-0793 |
0.425 |
|
| 2006 |
Hitchins M, Williams R, Cheong K, Halani N, Lin VA, Packham D, Ku S, Buckle A, Hawkins N, Burn J, Gallinger S, Goldblatt J, Kirk J, Tomlinson I, Scott R, et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology. 129: 1392-9. PMID 16285940 DOI: 10.1053/J.GASTRO.2005.09.003 |
0.41 |
|
| 2006 |
Johnson PM, Gallinger S, McLeod RS. Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: an evidence-based review. Diseases of the Colon and Rectum. 49: 80-93; discussion 94. PMID 16284887 DOI: 10.1007/s10350-005-0228-0 |
0.398 |
|
| 2006 |
Cotterchio M, Manno M, Klar N, McLaughlin J, Gallinger S. Colorectal screening is associated with reduced colorectal cancer risk: a case-control study within the population-based Ontario Familial Colorectal Cancer Registry. Cancer Causes & Control : Ccc. 16: 865-75. PMID 16132797 DOI: 10.1007/s10552-005-2370-3 |
0.414 |
|
| 2006 |
Townsley C, Brade AM, Brezden-Masley C, Hedley D, Gallinger S, Pond GR, Oza AM, Brierley J, Moore MJ. Long-term results of concurrent gemcitabine (G) and radiotherapy (GRT) for locally advanced (LA) or high-risk resected (R) pancreatic cancer Journal of Clinical Oncology. 24: 4101-4101. DOI: 10.1200/Jco.2006.24.18_Suppl.4101 |
0.328 |
|
| 2006 |
Lo DS, Pollett A, Gallinger S, Siu LL, Burkes RL. Prognostic significance of mesenteric tumor nodules in patients with stage III colorectal cancer Journal of Clinical Oncology. 24: 3566-3566. DOI: 10.1200/Jco.2006.24.18_Suppl.3566 |
0.442 |
|
| 2006 |
Durno CA, Berk T, Monga N, Cohen Z, Gallinger S. Early Colectomy And Genetic Predisposition Are Associated With The Development Of Desmoid Tumors In Familial Adenomatous Polyposis Journal of Pediatric Gastroenterology and Nutrition. 43. DOI: 10.1097/00005176-200610000-00075 |
0.322 |
|
| 2005 |
Hawkins MA, Eccles C, Lockwood G, Cummings B, Ringash J, Knox JJ, Sherman M, Greig P, Gallinger S, Dawson LA. Preliminary results of a phase I study of stereotactic radiotherapy for unresectable primary and metastatic liver cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 4127. PMID 27944809 DOI: 10.1200/Jco.2005.23.16_Suppl.4127 |
0.371 |
|
| 2005 |
Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S. Association between colonic screening, subject characteristics, and stage of colorectal cancer. The American Journal of Gastroenterology. 100: 2531-9. PMID 16279911 DOI: 10.1111/j.1572-0241.2005.00319.x |
0.371 |
|
| 2005 |
Bacani J, Zwingerman R, Di Nicola N, Spencer S, Wegrynowski T, Mitchell K, Hay K, Redston M, Holowaty E, Huntsman D, Pollett A, Riddell R, Gallinger S. Tumor microsatellite instability in early onset gastric cancer. The Journal of Molecular Diagnostics : Jmd. 7: 465-77. PMID 16237216 DOI: 10.1016/S1525-1578(10)60577-6 |
0.321 |
|
| 2005 |
Woods MO, Hyde AJ, Curtis FK, Stuckless S, Green JS, Pollett AF, Robb JD, Green RC, Croitoru ME, Careen A, Chaulk JA, Jegathesan J, McLaughlin JR, Gallinger SS, Younghusband HB, et al. High frequency of hereditary colorectal cancer in Newfoundland likely involves novel susceptibility genes. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6853-61. PMID 16203774 DOI: 10.1158/1078-0432.Ccr-05-0726 |
0.452 |
|
| 2005 |
Suriano G, Yew S, Ferreira P, Senz J, Kaurah P, Ford JM, Longacre TA, Norton JA, Chun N, Young S, Oliveira MJ, Macgillivray B, Rao A, Sears D, Jackson CE, ... ... Gallinger S, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5401-9. PMID 16061854 DOI: 10.1158/1078-0432.Ccr-05-0247 |
0.437 |
|
| 2005 |
Salahshor S, Goncalves J, Chetty R, Gallinger S, Woodgett JR. Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis. Bmc Cancer. 5: 66. PMID 15982419 DOI: 10.1186/1471-2407-5-66 |
0.364 |
|
| 2005 |
Batlle E, Bacani J, Begthel H, Jonkheer S, Jonkeer S, Gregorieff A, van de Born M, Malats N, Sancho E, Boon E, Pawson T, Gallinger S, Pals S, Clevers H. EphB receptor activity suppresses colorectal cancer progression. Nature. 435: 1126-30. PMID 15973414 DOI: 10.1038/Nature03626 |
0.341 |
|
| 2005 |
Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detection and Prevention. 29: 221-6. PMID 15896925 DOI: 10.1016/j.cdp.2005.04.001 |
0.378 |
|
| 2005 |
Gryfe R, Gallinger S. Germline PMS2 mutations: one hit or two? Gastroenterology. 128: 1506-1509. PMID 15887130 DOI: 10.1053/J.Gastro.2005.03.054 |
0.664 |
|
| 2005 |
Lindor NM, Rabe K, Petersen GM, Haile R, Casey G, Baron J, Gallinger S, Bapat B, Aronson M, Hopper J, Jass J, LeMarchand L, Grove J, Potter J, Newcomb P, et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Jama. 293: 1979-85. PMID 15855431 DOI: 10.1001/Jama.293.16.1979 |
0.492 |
|
| 2005 |
Casey G, Lindor NM, Papadopoulos N, Thibodeau SN, Moskow J, Steelman S, Buzin CH, Sommer SS, Collins CE, Butz M, Aronson M, Gallinger S, Barker MA, Young JP, Jass JR, et al. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. Jama. 293: 799-809. PMID 15713769 DOI: 10.1001/Jama.293.7.799 |
0.347 |
|
| 2005 |
Chetty R, Salahshor S, Bapat B, Berk T, Croitoru M, Gallinger S. Intraductal papillary mucinous neoplasm of the pancreas in a patient with attenuated familial adenomatous polyposis. Journal of Clinical Pathology. 58: 97-101. PMID 15623495 DOI: 10.1136/Jcp.2004.020925 |
0.397 |
|
| 2005 |
Tucker A, Cotterchio M, Gallinger S, Kreiger N, McLaughlin J, Koo M. 263-S: Access to an Educational Colorectal Cancer Website and Subject Participation in the Ontario Familial Colorectal Cancer Registry (OFCCR) American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S66B |
0.473 |
|
| 2005 |
Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S. 060-S: Association Between Subject Factors and Colorectal Cancer Screening Participation in Ontario, Canada American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S15C |
0.421 |
|
| 2005 |
Fazio L, Cotterchio M, Manno M, McLaughlin J, Gallinger S. 040-S: Association Between Colonic Screening, Subject Characteristics and Stage of Colorectal Cancer American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S10C |
0.435 |
|
| 2005 |
Cotterchio M, Boucher B, Manno M, Gallinger S. 039: Dietary Phytoestrogen Intake is Associated with Reduced Colorectal Cancer Risk American Journal of Epidemiology. 161. DOI: 10.1093/Aje/161.Supplement_1.S10B |
0.44 |
|
| 2004 |
Haddad R, Ogilvie RT, Croitoru M, Muniz V, Gryfe R, Pollet A, Shanmugathasan P, Fitzgerald T, Law CH, Hanna SS, Jothy S, Redston M, Gallinger S, Smith AJ. Microsatellite instability as a prognostic factor in resected colorectal cancer liver metastases. Annals of Surgical Oncology. 11: 977-82. PMID 15525826 DOI: 10.1245/Aso.2004.03.585 |
0.735 |
|
| 2004 |
Croitoru ME, Cleary SP, Di Nicola N, Manno M, Selander T, Aronson M, Redston M, Cotterchio M, Knight J, Gryfe R, Gallinger S. Association between biallelic and monoallelic germline MYH gene mutations and colorectal cancer risk. Journal of the National Cancer Institute. 96: 1631-4. PMID 15523092 DOI: 10.1093/jnci/djh288 |
0.76 |
|
| 2004 |
Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS, Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray B, MacLeod P, Micek M, ... ... Gallinger S, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. Journal of Medical Genetics. 41: 508-17. PMID 15235021 DOI: 10.1136/Jmg.2004.018275 |
0.472 |
|
| 2004 |
Cleary SP, Gryfe R, Guindi M, Greig P, Smith L, Mackenzie R, Strasberg S, Hanna S, Taylor B, Langer B, Gallinger S. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. Journal of the American College of Surgeons. 198: 722-31. PMID 15110805 DOI: 10.1016/J.JAMCOLLSURG.2004.01.008 |
0.688 |
|
| 2004 |
Gallinger S, Aronson M, Shayan K, Ratcliffe EM, Gerstle JT, Parkin PC, Rothenmund H, Croitoru M, Baumann E, Durie PR, Weksberg R, Pollett A, Riddell RH, Ngan BY, Cutz E, et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology. 126: 576-85. PMID 14762794 DOI: 10.1053/J.Gastro.2003.11.008 |
0.418 |
|
| 2004 |
Haddad R, Vincent JB, Gryfe R, Kim H, Wen J, Redston M, Scherer SW, Gallinger S. Chromosome 7q31 allelic imbalance and somatic mutations of RAY1/ST7 gene in colorectal cancer. Cancer Letters. 203: 87-90. PMID 14670621 DOI: 10.1016/J.Canlet.2003.08.003 |
0.729 |
|
| 2004 |
Croitoru M, Cleary S, Nicola ND, Manno M, Aaronson M, Redston M, Cotterchio M, Knight J, Gryfe R, Gallinger S. 476 Germline MYH mutations and risk of colorectal cancer Ejc Supplements. 2: 145. DOI: 10.1016/S1359-6349(04)80484-1 |
0.765 |
|
| 2004 |
Campbell PT, Manno M, McLaughlin JR, Cotterchio M, Klar N, Gallinger S. Body mass index and risk of colon and rectal cancer stratified by tumor location and sex Annals of Epidemiology. 14: 592-593. DOI: 10.1016/J.Annepidem.2004.07.003 |
0.411 |
|
| 2004 |
Wel AC, McGilvray ID, Grant D, Cattral M, Taylor B, Langer B, Greig P, Gallinger S. Survival following repeat hepatectomy for metastatic colorectal cancer Annals of Surgical Oncology. 11: S116-S117. DOI: 10.1007/Bf02524179 |
0.478 |
|
| 2003 |
Sahajpal A, Vollmer C, Pollett A, Gallinger S. Sclerosing pancreatitis presenting as a periampullary tumour Hpb. 5: 268-272. PMID 18333001 DOI: 10.1080/13651820310015761 |
0.302 |
|
| 2003 |
Esplen MJ, Urquhart C, Butler K, Gallinger S, Aronson M, Wong J. The experience of loss and anticipation of distress in colorectal cancer patients undergoing genetic testing. Journal of Psychosomatic Research. 55: 427-35. PMID 14581097 |
0.338 |
|
| 2003 |
Truta B, Allen BA, Conrad PG, Kim YS, Berk T, Gallinger S, Bapat B, Terdiman JP, Sleisenger MH. Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma. Familial Cancer. 2: 95-9. PMID 14574158 DOI: 10.1023/A:1025762706854 |
0.352 |
|
| 2003 |
Wright FC, Law CHL, Khalifa M, Arnaout A, Naseer Z, Klar N, Gallinger S, Smith AJ. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Annals of Surgical Oncology. 10: 903-909. PMID 14527909 DOI: 10.1245/Aso.2003.01.012 |
0.348 |
|
| 2003 |
Brezden-Masley C, Aronson MD, Bapat B, Pollett A, Gryfe R, Redston M, Gallinger S. Hereditary nonpolyposis colorectal cancer--molecular basis. Surgery. 134: 29-33. PMID 12874579 DOI: 10.1067/Msy.2003.176 |
0.741 |
|
| 2003 |
Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S. Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer The New England Journal of Medicine. 349: 247-257. PMID 12867608 DOI: 10.1056/Nejmoa022289 |
0.713 |
|
| 2003 |
Cleary SP, Zhang W, Di Nicola N, Aronson M, Aube J, Steinman A, Haddad R, Redston M, Gallinger S, Narod SA, Gryfe R. Heterozygosity for the BLM(Ash) mutation and cancer risk. Cancer Research. 63: 1769-71. PMID 12702560 |
0.766 |
|
| 2003 |
Campbell PT, Cotterchio M, Klar N, Mclaughlin JR, Gallinger S. Colorectal cancer risk among post-menopausal hormone users in a population-based familial case-control study Annals of Epidemiology. 13: 562. DOI: 10.1016/S1047-2797(03)00144-3 |
0.416 |
|
| 2002 |
Easson AM, Cotterchio M, Crosby JA, Sutherland H, Dale D, Aronson M, Holowaty E, Gallinger S. A population-based study of the extent of surgical resection of potentially curable colon cancer. Annals of Surgical Oncology. 9: 380-7. PMID 11986190 DOI: 10.1007/BF02573873 |
0.392 |
|
| 2002 |
Park J, Betel D, Gryfe R, Michalickova K, Di Nicola N, Gallinger S, Hogue CW, Redston M. Mutation profiling of mismatch repair-deficient colorectal cncers using an in silico genome scan to identify coding microsatellites. Cancer Research. 62: 1284-8. PMID 11888892 |
0.727 |
|
| 2002 |
Ghadirian P, Liu G, Gallinger S, Schmocker B, Paradis AJ, Lal G, Brunet JS, Foulkes WD, Narod SA. Risk of pancreatic cancer among individuals with a family history of cancer of the pancreas International Journal of Cancer. 97: 807-810. PMID 11857359 DOI: 10.1002/Ijc.10123 |
0.4 |
|
| 2002 |
Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 1043-8. PMID 11844828 |
0.355 |
|
| 2002 |
Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen GM, Walsh MD, Leggett BA, Young JP, Barker MA, Jass JR, Hopper J, Gallinger S, et al. Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors Journal of Clinical Oncology. 20: 1043-1048. DOI: 10.1200/Jco.20.4.1043 |
0.414 |
|
| 2001 |
Esplen MJ, Madlensky L, Butler K, McKinnon W, Bapat B, Wong J, Aronson M, Gallinger S. Motivations and psychosocial impact of genetic testing for HNPCC American Journal of Medical Genetics. 103: 9-15. PMID 11562928 DOI: 10.1002/Ajmg.1493 |
0.394 |
|
| 2001 |
Gryfe R, Gallinger S. Microsatellite instability, mismatch repair deficiency, and colorectal cancer Surgery. 130: 17-20. PMID 11436007 DOI: 10.1067/Msy.2001.112738 |
0.737 |
|
| 2001 |
Cotterchio M, McKeown-Eyssen G, Sutherland H, Buchan G, Aronson M, Easson AM, Macey J, Holowaty E, Gallinger S. Ontario familial colon cancer registry: methods and first-year response rates. Chronic Diseases in Canada. 21: 81-6. PMID 11007659 |
0.325 |
|
| 2000 |
Lal G, Gallinger S. Familial adenomatous polyposis. Seminars in Surgical Oncology. 18: 314-23. PMID 10805953 DOI: 10.1002/(sici)1098-2388(200006)18:4<314::aid-ssu6>3.0.co;2-9 |
0.354 |
|
| 2000 |
Lal G, Liu L, Hogg D, Lassam NJ, Redston MS, Gallinger S. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations. Genes, Chromosomes & Cancer. 27: 358-61. PMID 10719365 |
0.395 |
|
| 2000 |
Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M, Gallinger S. Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Research. 60: 409-16. PMID 10667595 |
0.377 |
|
| 2000 |
Gryfe R, Kim H, Hsieh ETK, Aronson MD, Holowaty EJ, Bull SB, Redston M, Gallinger S. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. The New England Journal of Medicine. 342: 69-77. PMID 10631274 DOI: 10.1056/Nejm200001133420201 |
0.761 |
|
| 1999 |
Vasen HFA, Bülow S, Järvinen H, Church J, Caspari R, Friedl W, Lamberti C, Slors J, Yuen ST, Cohen Z, Gallinger S, Babat B, Berk T, Haites N, Ward A, et al. Guidelines for the surveillance and management of familial adenomatous polyposis (FAP): a world wide survey among 41 registries. Colorectal Disease. 1: 214-221. PMID 23577809 DOI: 10.1046/J.1463-1318.1999.00050.X |
0.356 |
|
| 1999 |
Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LKF, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S, Redston M. Immunohistochemistry for hMLH1 and hMSH2: A practical test for DNA mismatch repair-deficient tumors American Journal of Surgical Pathology. 23: 1248-1255. PMID 10524526 DOI: 10.1097/00000478-199910000-00010 |
0.728 |
|
| 1999 |
Jiang CY, Esufali S, Berk T, Gallinger S, Cohen Z, Tobi M, Redston M, Bapat B. STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clinical Genetics. 56: 136-41. PMID 10517250 DOI: 10.1034/J.1399-0004.1999.560207.X |
0.33 |
|
| 1999 |
Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri C, Dale D, Holowaty E, Bapat B, Gallinger S, Redston M. Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Research. 59: 3346-51. PMID 10416591 |
0.343 |
|
| 1999 |
Bapat B, Noorani H, Cohen Z, Berk T, Mitri A, Gallie B, Pritzker K, Gallinger S, Detsky AS. Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut. 44: 698-703. PMID 10205208 DOI: 10.1136/Gut.44.5.698 |
0.455 |
|
| 1999 |
Millar AL, Pal T, Madlensky L, Sherman C, Temple L, Mitri A, Cheng H, Marcus V, Gallinger S, Redston M, Bapat B, Narod S. Mismatch repair gene defects contribute to the genetic basis of double primary cancers of the colorectum and endometrium Human Molecular Genetics. 8: 823-829. PMID 10196371 DOI: 10.1093/Hmg/8.5.823 |
0.469 |
|
| 1999 |
Bapat BV, Madlensky L, Temple LK, Hiruki T, Redston M, Baron DL, Xia L, Marcus VA, Soravia C, Mitri A, Shen W, Gryfe R, Berk T, Chodirker BN, Cohen Z, ... Gallinger S, et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Human Genetics. 104: 167-76. PMID 10190329 DOI: 10.1007/S004390050931 |
0.754 |
|
| 1999 |
Gryfe R, Nicola ND, Lal G, Gallinger S, Redston M. Inherited Colorectal Polyposis and Cancer Risk of the APC I1307K Polymorphism American Journal of Human Genetics. 64: 378-384. PMID 9973276 DOI: 10.1086/302262 |
0.766 |
|
| 1999 |
Soravia C, Sugg SL, Berk T, Mitri A, Cheng H, Gallinger S, Cohen Z, Asa SL, Bapat BV. Familial adenomatous polyposis-associated thyroid cancer: A clinical, pathological, and molecular genetics study American Journal of Pathology. 154: 127-135. PMID 9916927 |
0.33 |
|
| 1998 |
Soravia C, Berk T, Madlensky L, Mitri A, Cheng H, Gallinger S, Cohen Z, Bapat B. Genotype-phenotype correlations in attenuated adenomatous Polyposis coli American Journal of Human Genetics. 62: 1290-1301. PMID 9585611 DOI: 10.1086/301883 |
0.304 |
|
| 1998 |
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Current Problems in Cancer. 21: 233-300. PMID 9438104 DOI: 10.1016/S0147-0272(97)80003-7 |
0.764 |
|
| 1998 |
Temple L, Bapat B, Madlensky L, Redston M, Hiruki T, Cohen Z, McLeod R, Gallinger S. Hereditary non-polyposis colorectal cancer (HNPCC): Cancer patterns in germline mutation (hMSH2, hMLH1) positive (M+) and mutation negative (M−) families Gastroenterology. 114: A688. DOI: 10.1016/S0016-5085(98)82823-0 |
0.491 |
|
| 1997 |
Soravia C, Berk T, Haber G, Cohen Z, Gallinger S. Management of Advanced Duodenal Polyposis in Familial Adenomatous Polyposis Journal of Gastrointestinal Surgery. 1: 474-478. PMID 9834381 |
0.327 |
|
| 1997 |
Schnitzler M, Cohen Z, Blackstein M, Berk T, Gallinger S, Madlensky L, McLeod R. Chemotherapy for desmoid tumors in association with familial adenomatous polyposis Diseases of the Colon and Rectum. 40: 798-801. PMID 9221855 DOI: 10.1007/Bf02055435 |
0.317 |
|
| 1997 |
Özcelik H, Schmocker B, Nicola ND, Shi X, Langer B, Moore M, Taylor BR, Narod SA, Darlington G, Andrulis IL, Gallinger S, Redston M. Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nature Genetics. 16: 17-18. PMID 9140390 DOI: 10.1038/Ng0597-17 |
0.402 |
|
| 1997 |
Richard CS, Berk T, Bapat BV, Haber G, Cohen Z, Gallinger S. Sulindac for periampullary polyps in FAP patients International Journal of Colorectal Disease. 12: 14-18. PMID 9112144 DOI: 10.1007/S003840050071 |
0.345 |
|
| 1997 |
Madlensky L, Bapat B, Redston M, Pearl R, Gallinger S, Cohen Z. Using genetic information to make surgical decisions: Report of a case of a 13-year-old boy with colon cancer Diseases of the Colon and Rectum. 40: 240-243. PMID 9075764 DOI: 10.1007/Bf02054995 |
0.502 |
|
| 1996 |
Belchetz LA, Berk T, Bapat BV, Cohen Z, Gallinger S. Changing causes of mortality in patients with familial adenomatous polyposis. Diseases of the Colon and Rectum. 39: 384-7. PMID 8878496 DOI: 10.1007/BF02054051 |
0.369 |
|
| 1996 |
Reitmair AH, Cai JC, Bjerknes M, Redston M, Cheng H, Pind MT, Hay K, Mitri A, Bapat BV, Mak TW, Gallinger S. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Research. 56: 2922-6. PMID 8674041 |
0.355 |
|
| 1996 |
Xia L, Shen W, Ritacca F, Mitri A, Madlensky L, Berk T, Cohen Z, Gallinger S, Bapat B. A truncated hMSH2 transcript occurs as a common variant in the population: Implications for genetic diagnosis Cancer Research. 56: 2289-2292. PMID 8625301 |
0.348 |
|
| 1996 |
Sanabria JR, Croxford R, Berk TC, Cohen Z, Bapat BV, Gallinger S. Familial segregation in the occurrence and severity of periampullary neoplasms in familial adenomatous polyposis. American Journal of Surgery. 171: 136-40; discussion 1. PMID 8554128 DOI: 10.1016/S0002-9610(99)80088-9 |
0.327 |
|
| 1996 |
Cole DEC, Gallinger S, McCready DR, Rosen B, Engel J, Malkin D. Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: Where are we today? Cmaj. 154: 149-155. PMID 8548703 |
0.399 |
|
| 1995 |
Madlensky L, Berk TC, Bapat BV, McLeod RS, Couture J, Baron D, Hiruki T, Redston M, Cohen Z, Gallinger S. A preventive registry for hereditary nonpolyposis colorectal cancer The Canadian Journal of Oncology. 5: 355-360. PMID 8853507 |
0.382 |
|
| 1995 |
Denis K, Mitri A, Berk T, Hiruki T, Gallinger S, Cohen Z, Bapat B. Unequal expression of APC alleles in colorectal adenomas of patients with familial adenomatous polyposis (FAP) Gastroenterology. 108: A540. DOI: 10.1016/0016-5085(95)26473-6 |
0.403 |
|
| 1995 |
Bapat B, Xia L, Berk T, Nong Y, Gallinger S. Isolation of differentially expressed messenger RNAs from peri-ampullary cancer associated with familial adenomatous polyposis (FAP) Gastroenterology. 108: A447. DOI: 10.1016/0016-5085(95)26103-6 |
0.364 |
|
| 1994 |
Smith AJ, Stern HS, Penner M, Hay K, Mitri A, Bapat BV, Gallinger S. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Research. 54: 5527-30. PMID 7923190 |
0.324 |
|
| 1993 |
Bapat B, Odze R, Mitri A, Berk T, Ward M, Gallinger S. Identification of somatic APC gene mutations in periampullary adenomas in a patient with familial adenomatous polyposis (FAP) Human Molecular Genetics. 2: 1957-1959. PMID 8281160 DOI: 10.1093/Hmg/2.11.1957 |
0.395 |
|
| 1990 |
Gallinger S, Gluckman D, Langer B. Proximal bile duct cancer. Advances in Surgery. 23: 89-118. PMID 2403463 |
0.371 |
|
| Show low-probability matches. |